Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology | Musculoskeletal
Leukemia Clinical Trials
A listing of Leukemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : University of Alabama Comprehensive Cancer Center University of Alabama
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Birmingham : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Birmingham : University of Alabama at Birmingham
A Safety Study of SGN-CD19A for B-Cell Lymphoma
Birmingham : UAB Comprehensive Cancer Center
A Safety Study of SGN-CD19A for Leukemia and Lymphoma
Birmingham : University of Alabama Comprehensive Cancer Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
View More »
Birmingham : University of Alabama at Birmingham
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Birmingham : University of Alabama at Birmingham
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Birmingham : Uab Comprehensive Cancer Center
First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
Birmingham : The Children's Hospital of Alabama, University of Alabama at Birmingham
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Birmingham : University of Alabama, Birmingham
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Birmingham : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Birmingham : University Of Alabama At Birmingham
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Birmingham : University of Alabama at Birmingham
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Huntsville : Clearview Cancer Institute
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Huntsville : Clearview Cancer Institute
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Huntsville : Clearview Cancer Institute
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Huntsville : Clearview Cancer Institute
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Huntsville : Clearview Cancer Institute
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Huntsville : Clearview Cancer Center
Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
Huntsville : Clearview Cancer Institute Updated
Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Huntsville : TG Therapeutics Investigational Trial Site
Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Huntsville : Clearview Cancer Institute
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Huntsville : TG Therapeutics Investigational Trial Site
Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies
Muscle Shoals : Northwest Alabama Cancer Center, PC
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Muscle Shoals : Northwest Alabama Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Arizona
Phoenix : Phoenix Children'S Hospital
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Phoenix :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Phoenix : Phoenix Children's Hospital
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Phoenix : Phoenix Children's Hospital
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Scottsdale : Mayo Clinic Arizona - Cancer Clinical Research Unit
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
View More »
Scottsdale : Site Reference ID/Investigator# 59324
ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies
Scottsdale : Virginia G. Piper Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Scottsdale : Mayo Clinic
SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Scottsdale : Call for Information (Investigational Site 0004)
Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)
Sedona : Arizona Oncology Associates, PC - NAHOA
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Tucson : Arizona Oncology Associates
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Tucson : Arizona Oncology Associates
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Tucson : University of Arizona (SPORE)
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Tucson : Arizona Oncology Associates, PC - HOPE
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Arkansas
Hot Springs : Investigational Site Number 840018
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Hot Springs National Park : Genesis Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Jonesboro : GSK Investigational Site
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Jonesboro : NEA Baptist Clinic
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Little Rock : University Of Arkansas For Medical Sciences
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
View More »
Little Rock : Little Rock Hematology Oncology Associates
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
California
Duarte : City of Hope
An Open Label, Multicenter, Phase II Study to Evaluate Efficacy and Safety of the BiTE Antibody Blinatumomab in Adult Patients with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)
Duarte : City of Hope
COG #AALL0434: Intensified Methotrexate, Nelarabine (Compound 506U78; IND #52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia
Duarte : City of Hope
COG AALL08B1 - Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Duarte : City of Hope
COG AALL0932: Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymhoblastic Leukemia (ALL)
Duarte : City of Hope
COG AALL1131: A Phase III Randomized Trial for Newly Diagnosed High Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)Testing Clofarabine (IND#73789, NSC# 606869) in the Very High Risk Stratum
Duarte : City of Hope
Mechanisms of Response and Resistance to STI571 in CML
Duarte : City of Hope
Molecular Pathogenesis of Acute Leukemia and Myelodysplasia
Duarte : City of Hope
Molecular Pathogenesis of Therapy-Related Leukemia
Duarte : City of Hope
SWOG S0805: Phase II Study of Combination of Hyper-CVAD and Dasatinib (NSC-732517) with or without Allogeneic Stem Cell Transplant in Patients with Philadelphia (Ph) Chromosome Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL) (A BMT Study)
Duarte : City of Hope
SWOG S1117: A Randomized Phase II Study of Azacitidine in Combination with Lenalidomide (NSC-703813) vs. Azacitidine Alone vs. Azacitidine in Combination with Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
View More »
Anaheim : Pacific Cancer Medical Center, Inc.
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Anaheim : Pacific Cancer Medical Center, Inc
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Anaheim : Pacific Cancer Medical Center
This Study Will be a Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib
Burbank : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Burbank : Providence St. Joseph Medical Center Roy&Patricia Disney Fam Cancer
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Burbank : East Valley Hematology and Oncology Medical Group
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Burbank : US Oncology - Providence Health System, Site #167
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Concord : Bay Area Cancer Research Dept.ofBayAreaCancerResearch
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Concord : Bay Area Cancer Research Group
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Duarte : City of Hope National Medical Center Updated
A Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 Versus Chlorambucil in Patients 65 Years or Older With Treatment-naive Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (RESONATE™-2)
Duarte : City of Hope National Medical Center
A Safety Study of SGN-CD19A for Leukemia and Lymphoma
Duarte : City of Hope
A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)
Duarte : City of Hope
A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Duarte : City of Hope National Medical Center Updated
An Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Who Participated in Study PCYC-1115-CA (PCI-32765 Versus Chlorambucil)
Duarte : City of Hope
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Duarte : City of Hope National Medical Center
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Duarte : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Duarte : City of Hope
Safety and Efficacy Study of PD-616 Plus Cytarabine to Treat Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Escondido : Southwest Cancer Care Medical Group
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Fountain Valley : Lalita Pandit, MD, Inc.
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Fountain Valley : Pacific Coast Hematology/Oncology Medical Group, Inc.
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Fountain Valley : Robert A. Moss, M.D. FACP, Inc.
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Glendora : Wilshire Oncology Medical Group, Inc
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Hayard : Kaiser Permanente Northern California
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
La Jolla : University of California, San Diego - Moores Cancer Center
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
La Jolla : Moores UCSD Cancer Center
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
La Jolla : Univ. of San Diego: Moores UCSD Cancer Center
A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
La Jolla : University of California, San Diego/Moores Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
La Jolla : University of California, San Diego- Moores Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
La Jolla : (180) University of California, San Diego
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
La Jolla : Scripps Cancer Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
La Jolla : Scripps Cancer Center
A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia
La Jolla : Moores UCSD Cancer Center
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
La Jolla : Moores Ucsd Cancer Center
First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
La Jolla : University of California, San Diego
Multi-center Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
La Jolla : University of California San Diego
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
La Jolla : Danelle James, M.D.
Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)
La Jolla : University of California San Diego, Moores Cancer Center
Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)
La Jolla : University of California San Diego Moores Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
La Jolla : Moores UCSD Cancer Center
Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia
La Jolla : University of California, San Diego
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
La Jolla : Moores UCSD Cancer Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
La Jolla : UCSD Medical Center
Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)
La Jolla : Moores UCSD Cancer Center
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
LaJolla : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
LaVerne : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Loma Linda : Loma Linda University
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Loma Linda : Antranik Agop Bedros
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Long Beach : Jonathan Jaques Children'S Cancer Center
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Long Beach : Miller Children's Hospital Long Beach
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Long Beach : Miller Children's Hospital
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Los Angeles : UCLA
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Los Angeles : Childrens Hospital Los Angeles
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Los Angeles : Children's Hospital of Los Angeles Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Los Angeles : Investigational Site Number 840012
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Los Angeles : UCLA Ronald Reagan Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Los Angeles : Childrens Hospital Los Angeles
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Los Angeles : Childrens Hospital Los Angeles
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
Los Angeles : Cedars-Sinai Medical Center
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
Los Angeles : UCLA
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Los Angeles : UCLA School of Medicine
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Los Angeles : Metropolitan Hematology Oncology Medical Group
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Los Angeles : UCLA Division of Hematology-Oncology
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Los Angeles : Ucla-Division Of Hematology/Oncology
First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
Los Angeles : Usc - Norris Comprehensive Cancer Center And Hospital
First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
Los Angeles : Cedars-Sinai Medical Center
KW 0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)
Los Angeles : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Los Angeles : Children'S Hospital Of L.A.
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Los Angeles : Division Of Hematology & Oncology Ctr. For Health Sciences
Safety Study of Anti-Programmed Death-1 in Hematologic Malignancy
Los Angeles : University of Southern California
SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Los Angeles : UCLA Division of Hematology/Oncology
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Los Angeles : UCLA
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Los Angeles : University of Southern California
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Los Angeles : Childrens Hospital Los Angeles
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Los Angelos : UCLA - David Geffen School of Medicine
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Madera :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Mission Hills : Providence Holy Cross Medical Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Oakland : Oakland Children's Hospital
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Oceanside : North County Oncology
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Orange : Children's Hospital of Orange County CHOC
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Orange : Children'S Hospital Of Orange County
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Orange : (215) Hematology Oncology Medical Group
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
Orange : Children's Hospital of Orange County CHOC Cancer Institute
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
Orange : Children'S Hospital Of Orange County
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Orange County : Children's Hospital of Orange County Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Oxnard : Ventura County Hematology Oncology Specialists
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Oxnard : Ventura County Hematology Oncology Specialists
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Oxnard : PMK Medical Group Inc., DBA Ventura County Hematology Oncology Specialists
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Oxnard : Ventura County Hematology Oncology Specialists
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Oxnard : PMK Medical Group, Inc. DBA Ventura
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Palm Springs : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Palo Alto : Stanford University Medical Center Oncology
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Palo Alto : Stanford Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Palo Alto : Stanford Medical Center Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Palo Alto : Stanford Cancer Center
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Palo Alto : Stanford University Medical Center
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Palo Alto : Lpch & Sumc
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Palo Alto : Stanford Cancer Center
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Palo Alto : Stanford University Medical Center
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Pleasant Hill : Bay Area Cancer Research Group, Site #156
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Pleasant Hill : Bay Area Cancer Research Group, Site #157
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Rancho Mirage : Cancer and Blood Institute Medical Group
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Roseville : Kaiser Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Sacramento : Univeristy of California Davis Medical Center
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
Sacramento : University of California Comprehensive Cancer Center
Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia
Sacramento : University of California Comprehensive Cancer Center
Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma
Sacramento : University of California Comprehensive Cancer Center
Phase I Study of Lenalidomide in Patients With Acute Leukemia
Sacramento : University of California Davis
Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
San Diego : Kaiser Permanente Medical Group
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
San Diego : Rady Children's Hospital
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
San Diego : Moores UCSD Cancer Center
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
San Diego : University of CA San Diego
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
San Diego : Sharp Clinical Oncology Research
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
San Francisco : UCSF School of Medicine
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
San Francisco : University of California San Francisco
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
San Francisco : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
San Francisco : UCSF Helen Diller Family Family Comprehensive Cancer Center
Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
San Francisco : University of California Medical Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
San Francisco : University of California San Francisco
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
San Francisco : UCSF School of Medicine
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
San Luis Obispo : (200) Coastal Integrative Cancer Care
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
San Pablo : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Santa Maria : Central Coast Medical Oncology Corp.
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Santa Monica : UCLA Medical Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Santa Monica : UCLA
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Santa Monica, : Sarcoma Oncology Center
Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia
Stanford : Stanford Cancer Center
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Stanford : Stanford University School of Medicine
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Stanford : Stanford Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Stanford : (125) University of Stanford
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
Stanford : Stanford Cancer Center - Stanford University
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Stanford :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Stanford :
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma
Stanford : Stanford Cancer Center
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Stanford : Stanford University
A Trial of the Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)
Stanford : Stanford University School of Medicine
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
Stanford : Stanford University School of Medicine
Azacitidine + Lenalidomide Combo in the Elderly Previously Treated Acute Myeloid Leukemia (AML) & High-Risk Myelodysplastic Syndromes (MDS)
Stanford : Stanford University Medical Center
MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
Stanford : Stanford University School of Medicine
Phase II Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma
Stanford : Stanford University
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Stanford : Stanford University School of Medicine
Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia
Stanford : Stanford Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Stanford : Stanford University Medical Center Stanford U
Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
Stanford : Stanford University Medical Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Stanford : Pfizer Investigational Site
Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia
Stanford : Stanford University Medical Center, BMT
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Stockton : St. Teresa Comprehensive Cancer Center
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Sylmar : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Vista : Medical Group of North County
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Yorba Linda : St. Jude Heritage Medical Group Virginia Crosson Cancer Center
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Colorado
Aurora : Children'S Hospital
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Aurora : (115) University of Colorado Anschultz Cancer Center
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
Aurora : Children's Hospital Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Aurora : Pfizer Investigational Site
A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Aurora : University of Colorado Cancer Center
Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia
View More »
Aurora : Children's Hospital Denver
Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Aurora :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Aurora : The Children's Hospital Colorado
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Aurora : Children'S Hospital Colorado
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Aurora : Investigational Site Number 840004
Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia
Boulder : Rocky Mountain Cancer Centers
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Colorado Springs : The Oncology Clinic, PC
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Denver : Rocky Mountain Blood and Marrow Transplant Program
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Denver : Rocky Mountain Cancer Center
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Denver : Rocky Mountain Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Denver : Rocky Mountain Blood and Marrow Transplant Program
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Denver : Rocky Mountain Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Denver :
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma
Denver : Rocky Mountain Cancer Centers - Denver
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Denver : Mile High Oncology
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Denver : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Denver : Rocky Mountain Cancer Centers
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
Denver : HCA HealthONE - Rocky Mountain Blood and Marrow Transplant Program
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Fort Collins : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Connecticut
Hartford : Connecticut Children'S Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Manchester : Medical Oncology and Blood Disorders, LLP
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New Haven : Yale Cancer Center
Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia
New Haven : Yale Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Norwalk : Whittingham Cancer Center at Norwalk Hospital
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
View More »
Norwalk : Norwalk Hospital
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Southington : Cancer Center of Central Connecticut
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Southington : Cancer Center of Central Connecticut
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Southington : Cancer Center of Central Connecticut, Site #147
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Southington : Cancer Center Of Central Connecticut
This Study Will be a Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib
Delaware
Wilmington : A. I. Dupont Hospital For Children
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
District of Columbia
Washington : Georgetown University Medical Center Lombardi Cancer Center
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Washington : Georgetown University Medical Center Lombardi Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Washington :
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma
Washington : Children's National Medical Center
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Washington : Children'S National Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
View More »
Washington : Georgetown University Hospital
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Washington : George Washington University-Medical Faculty Associates
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Florida
Atlantis : Medical Specialists of the Palm Beaches
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Boca Raton :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Boca Raton : Boca Raton Community Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Boynton Beach : Collaborative Research Group
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Boynton Beach : Collaborative Research Group LLC
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
View More »
Boynton Beach : University Cancer Institute
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Boynton Beach : Thomas Niederman, MD
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Boynton Beach : Palm Beach Institute of Hematology and Oncology
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Boynton Beach : University Cancer Institute, Site #149
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Boynton Beach : Hematology And Medical Oncology Of Southern Palm Beach County
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Fort Lauderdale : Holy Cross Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Fort Meyers : Investigational Site Number 840104
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Fort Myers : Florida Cancer Specialists
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Fort Myers : Florida Cancer Specialists
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Fort Myers : Lee Memorial Health System
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Ft. Lauderdale : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Gainsville : University of Florida
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Gainsville : University of Florida
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Gainsville : University of Florida
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Hialeah : Palm Springs Research Institute
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Jacksonville : Mayo Clinic Jacksonville
A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)
Jacksonville : Integrated Community Oncology Network
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Jacksonville : Mayo Clinic
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Jacksonville : Nemours Children'S Clinic
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Jacksonville : Integrated Community Oncology Network
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Jacksonville : Baptist Cancer Institute
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Jacksonville : Baptist Cancer Institute
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Jacksonville : University Of Florida
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Kissimmee : Osceola Cancer Center
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Lakeland : Watson Clinic
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Miami : University of Miami
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Miami : Advanced Medical Specialties
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Miami :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Miami : Miami Children's Hospital
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Miami : Innovative Medical Research of South Florida, Inc.
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Miami : University of Miami Cancer Center
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Miami Beach : (145) Mount Sinai Comprehensive Cancer Center
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
Miami Beach : Mount Sinai Comprehensive Cancer Centers
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
New Port Richey : Pasco Hernando Oncology Associates (Kumar)
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
New Port Richey : Pasco Pinellas Cancer Center
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
New Port Richey : Pasco Hernando Oncology Associates, PA
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
New Port Richey : Florida Cancer Specialists
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Ocala : Ocala Oncology Center
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Orlando : Md Anderson Cancer Center Orlando
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Orlando : Nemours Children'S Clinic - Orlando
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Orlando : Cancer Centers of Florida
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Pembroke Pines : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Pensacola : Woodlands Medical Specialists
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Sarasota :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
St. Petersburg : Florida Cancer Specialists
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
St. Petersburg : Florida Cancer Specialists
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
St. Petersburg : All Children's Hospital
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
St. Petersburg : All Children'S Hospital
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
St. Petersburgh : All Children's Hospital Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Stuart : Martin Memorial Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Tampa : H. Lee Moffitt Cancer Center & Research Institute
A Safety Study of SGN-CD19A for Leukemia and Lymphoma
Tampa : H. Lee Moffitt Cancer Center and Research Institute
A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib
Tampa : H. Lee Moffitt Cancer Center & Research Institute
CNDO-109-AANK for AML in First Complete Remission (CR1)
Tampa : H. Lee Moffitt Cancer Center & Research Institute
Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)
Tampa : H. Lee Moffitt Cancer Center and Research Institute
Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Tampa : H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Study of Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)
Tampa : H. Lee Moffitt Cancer Center and Research Institute
Phase II Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Tampa : H. Lee Moffitt Cancer Center
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Tampa : H. Lee Moffitt Cancer Center and Research Institute Updated
Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients
Tampa : Moffitt Cancer Center
Study of KB004 in Subjects With Hematologic Malignancies
Tampa : Call for Information (Investigational Site 0006)
Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)
Tampa : H. Lee Moffitt Cancer Center
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
Tampa : Moffitt Cancer Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Tampa : H. Lee Moffitt Cancer Center & Research Institute
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Tavares : Lake County Oncology and Hematology
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Tavares : Lake County Oncology and Hematology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Titusville : Space Coast Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
West Palm Beach : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Weston : Cleveland Clinic Florida
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Weston : Cleveland Clinic Florida
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Georgia
Albany : Phoebe Putney Memorial Hospital
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Atlanta : Peachtree Hematology Oncology Consultants Updated
A Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 Versus Chlorambucil in Patients 65 Years or Older With Treatment-naive Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (RESONATE™-2)
Atlanta : Emory University, Winship Cancer Institute
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Atlanta : Aflac Cancer Center & Blood Disorders Service
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Atlanta : Emory University, Winship Cancer Institute
A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
View More »
Atlanta : Emory University, Winship Cancer Institute
A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
Atlanta : Blood and Marrow Transplant Group of Georgia
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Atlanta : Winship Cancer Institute, Emory University
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Atlanta : Northside Hospital/BMTGA
A Trial of the Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)
Atlanta : Site Reference ID/Investigator# 26523
ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies
Atlanta : Peachtree Hematology Oncology Consultants Updated
An Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Who Participated in Study PCYC-1115-CA (PCI-32765 Versus Chlorambucil)
Atlanta : Winship Cancer Institute of Emory University
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Atlanta : Children's Healthcare of Atlanta at Egleston
Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Atlanta : Georgia Cancer Specialists
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Atlanta : Peachtree Hematology-Oncology Consultants
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Atlanta :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Atlanta : Winship Cancer Institute
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Atlanta : Children's Healthcare of Atlanta
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Atlanta : Northside Hospital
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Atlanta : Emory University, Site #058
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Atlanta : Emory University Winship Cancer Institute
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Atlanta : Emory University
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Atlanta : Children's Healthcare of Atlanta, Emory University
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Augusta : Investigational Site Number 840006
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Augusta : Georgia Health Sciences University
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Augusta : Augusta Oncology Associates, PC
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Augusta : For additional information regarding sites for this trial call (919) 465-4648
Phase 1b Safety and Efficacy Study of TRU-016 and Rituximab in Previously Untreated Chronic Lymphocytic Leukemia
Augusta : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Augusta : Investigational Site Number 840006
Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia
Augusta : Georgia Health Sciences University
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Dublin : US Oncology - Dublin Hematology & Oncology
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Griffin : Spalding Oncology Services
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Marietta : Northwest Georgia Oncology Center
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Marietta :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Marietta : Northwest Georgia Oncology Centers, PC
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Sandy Springs : Georgia Cancer Specialist
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Savannah : Lewis Cancer Center and Research Pavilion
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
Hawaii
Honolulu : Straub Clinic and Hospital
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Honolulu : Straub Clinical & Hospital
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Honolulu : OnCare
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Idaho
Boise : St Luke's Mountain States Tumor Institute
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Post Falls : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Illinois
Elgin : Sherman Health
E2906 - Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age>/=60 Years
Elgin : Sherman Health
ECOG E2903 Phase II Trial of Pentostatin, Cyclophosphamide and Rituximab (PCR) Followed By Campath-1H For Previously Treated Relapsed or Refractory Patients With Chronic Lymphocytic Leukemia
Elgin : Sherman Health
S0919 - Phase II A Phase II Study of Idarubicin and Ara-C in Combination with Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
View More »
Arlington Heights : US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Arlington
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Chicago : Northwestern University
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Chicago : University of Chicago - Oncology Dept Updated
A Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 Versus Chlorambucil in Patients 65 Years or Older With Treatment-naive Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (RESONATE™-2)
Chicago : Ann & Robert H. Lurie Children's Hospital of Chicago Ann&Robert Lurie
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Chicago : University of Chicago
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Chicago : Northwestern University Fienberg School of Medicine
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Chicago : Children'S Memorial Hospital
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Chicago : Northwestern University
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Chicago : Northwestern University
A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)
Chicago : Children's Memorial Hospital Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Chicago :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Chicago : Northwestern Memorial Hospital
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Chicago : The University of Chicago Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Chicago : Rush University Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Chicago : Ann & Robert H. Lurie Children's Hospital of Chicago SC
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
Chicago : Northwestern University
A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)
Chicago : Pfizer Investigational Site
A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Chicago : Northwestern University
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Chicago : Northwestern University
Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia
Chicago : University of Chicago
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Chicago : Northwestern University
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Chicago : University of Chicago - Oncology Dept Updated
An Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Who Participated in Study PCYC-1115-CA (PCI-32765 Versus Chlorambucil)
Chicago : 1315.1.1003 Boehringer Ingelheim Investigational Site
BI 836858 Dose Escalation in Refractory or Relapsed Acute Myeloid Leukemia
Chicago : Rush University Medical Center
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Chicago : University of Chicago
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Chicago : University of Chicago
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Chicago : Stroger Cook County Hospital Division of Hematology & Onc
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Chicago : John H. Stroger, Jr., Hospital of Cook County
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Chicago : Rush University Medical Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Chicago : Northwestern University Feinberg School of Medicine
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Chicago : Rush University Medical Center
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Chicago : University of Chicago Cancer Research Center
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Chicago : Northwestern University
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Chicago : Robert H. Lurie Comprehensive Cancer Center Northwestern University
MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
Chicago : Children's Memorial Hospital
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Chicago : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Chicago : Children'S Hospital Of Chicago
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Chicago : Northwestern University
Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Chicago : University of Chicago
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Chicago : Northwestern University
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Chicago : University of Chicago, Site #001
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Chicago : Rush University Medical Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Chicago : University of Chicago Medical Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Chicago : Children's Memorial Hospital
Reduced Intensity Transplant Using Extracorporeal Photopheresis
Chicago : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Chicago : University of Chicago Cancer Center
SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Chicago : Pfizer Investigational Site
Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia
Chicago : University of Chicago Medical Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Chicago : University of Chicago
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Chicago : Rush University Medical Center, Division of Hematology/Oncology
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Chicago : Northwestern University Feinberg School of Medicine
TK008: Efficacy Study on the Strategy of Herpes Simplex Virus Thymidine Kinase Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia
Chicago : Northwestern University
Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission
Evanston : North Shore Medical Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Evergreen Park : Mahafzah Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Gurnee : Oncology Hematology Assoc. of Northern Illinois
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Harvey : Ingalls Cancer Research Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Hines : Edward Hines Jr. VA Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Lombard : Elmhurst Memorial Hospital
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Maywood : Investigational Site Number 840011
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Maywood : Cardinal Bernardin Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Maywood : Loyola University Medical Center, Cardinal Bernardin Cancer Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Maywood : Loyola University Medical Center, Cardinal Bernardin Cancer Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Maywood : Loyola University Medical Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Niles : Oncology Specialists, S.C.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Niles : US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Niles : Orchard Health Care Research
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Normal : Mid-Illinois Hem/Onc Asoc
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
North Chicago : North Chicago VA Medical Center
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
North Chicago : North Chicago VA Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Peoria : Illinois Cancer Care
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Skokie : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Skokie : Hematology Oncology Assoc. of IL.
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Skokie : Orchard Research
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Skokie : Edward H. Kaplan MD & Associates
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Springfield : Southern Illinois University School Of Medicine
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Springfield : Southern Illinois School of Medicine
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Urbana : Carle Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Winfield : US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Winfield
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Indiana
Anderson : Saint John's Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Beach Grove : Indiana Blood and Marrow Institute
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Beech Grove : St. Francis Cancer Research
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Beech Grove : Indiana Blood and Marrow Transplantation, LLC
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Evansville : Deaconess Clinic, Inc.
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
View More »
Goshen :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Goshen : Center for Cancer Care @ Goshen Health Systems
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Indianapolis : Indiana University Riley Hospital for Children
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Indianapolis :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Indianapolis : St. Francis Medical Group Oncology and Hematology Specialits
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Indianapolis : Indiana University Simon Cancer Center IU Simon Cancer Center Clinical Research Office, RT 380
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Indianapolis : Indiana University Cancer Center Clinical Research Office
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Indianapolis : Indiana Oncology Hematology Consultants
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Indianapolis : Riley Hospital for Children/Indiana University
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Indianapolis : Children'S Center For Cancer And Blood Diseases
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Indianapolis : James Whitcomb Riley Hospital For Children
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Indianapolis : Indiana University Melvin and Bren Simon Cancer Center
Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib for the Treatment of Acute Myeloid Leukemia With Complex- or Poor-risk (Monosomy 5/7) Cytogenetics or FLT3-ITD Positive Genotype
Indianapolis : Franciscan St. Francis Health
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Indianapolis : Indiana University Melvin and Bren Simon Cancer Center
Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia
Indianapolis : Franciscan St. Francis Health, Site #138
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Indianapolis : Indiana University Simon Cancer Center
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
Indianapolis : Indiana University Melvin and Bren Simon Cancer Center
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Indianapolis : St. Francis Medical Group Oncology and Hematology Specialists
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Indianapolis : Investigative Clinical Research of Indiana
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Indianapolis : Indiana Blood and Marrow Transplantation
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Lafayette : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Lafayette : Arnett Cancer Care
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Lafayette : Horizon Oncology Center
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Lafayette : Horizon Oncology Research
Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
Lafayette : Horizon Oncology Research, Inc Updated
Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Mishawaka : Cancer Care Partners, LLC
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
New Albany : Cancer Care Center, Inc.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
New Albany : Cancer Care Center
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
New Albany : Cancer Care Center, Inc. PC
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Iowa
Ames : McFarland Clinic
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Bettendorf : Hematology Oncology Associates of the Quad Cities
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Cedar Rapids : Iowa Blood and Cancer Care of PCI
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Iowa City :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Iowa city : University of Iowa Hospitals and Clinics
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
View More »
Iowa City : University of Iowa Hospitals and Clinics
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Mason City : N. Iowa Mercy Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Waterloo : Covenant Clinic
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Kansas
Hutchinson : Hutchinson Clinic
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Kansas City : Investigational Site Number 840010
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Kansas City : University of Kansas Medical Center
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Kansas City : University of Kansas Medical Center, Westwood Campus
Safety Study: Combination of Decitabine and Midostaurin in Patients Older Than 60 With Newly Diagnosed or Relapsed Refractory Acute Myeloid Leukemia
Kansas City : University of Kansas Medical Center
Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease
View More »
Topeka : Cotton O'Neil Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Westwood : (185) The University of Kansas Cancer Center
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
Westwood : University of Kansas Medical Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Westwood : University of Kansas Medical Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Wichita : Cancer Center of Kansas, PA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Wichita : US Oncology - Cancer Center of Kansas, Site #168
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Wichita : Cancer Center of Kansas
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Witchita : Cancer Center of Kansas
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Kentucky
Hazard : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Hazard : Kentucky Cancer Clinic
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Lexington : Investigational Site Number 840013
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Lexington : Central Baptist Hospital
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Louisville : (175) University of Kentucky, Lousiville James Graham Brown Cancer Center
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
View More »
Louisville :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Louisville : University of Louisville
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Paducah :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Paducah : Investigational Site Number 840007
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Louisiana
Baton Rouge : Mary Bird Perkins Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Baton Rouge : Mary Bird Perkins Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Marrero :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Metairie : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
New Orleans : (195) Tulane University Hospital Tulane Cancer Center
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
View More »
New Orleans : Ochsner Medical Institutions
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
New Orleans : LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Feist-Weiller Cancer Center(3)
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
New Orleans : Tulane University Health Sciences Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
New Orleans : Ochsner Clinic Foundation
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Shreveport : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Shreveport : Willis-Knighton Cancer System
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Maryland
Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias and High-Risk Myelodysplasia
Baltimore : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Baltimore : Sidney Kimmel Cancer Center at Johns Hopkins
A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
Baltimore : John Hopkins Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Baltimore :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
View More »
Baltimore : University of Maryland Greenbaum Cancer Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Baltimore : Johns Hopkins Medical Institute
A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)
Baltimore : University of Maryland Greenebaum Cancer Center
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Baltimore : John Hopkins University
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Baltimore : U of Maryland
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Baltimore :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Baltimore : Auerbach Hematology Oncology Associates, Inc.
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Baltimore : Greater Baltimore Medical Center
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Baltimore : Chesapeake Oncology Hematology Associates
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Baltimore : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Baltimore : B. Douglas Smith, M.D.
First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
Baltimore : Johns Hopkins Kimmel Cancer Center
MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
Baltimore : Johns Hopkins
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Baltimore : Johns Hopkins University
Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Baltimore : Greater Baltimore Medical Center, Site #140
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Baltimore : University of Maryland, Greenebaum Cancer Center, Site #040
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Baltimore : University of Maryland Greenebaum Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Baltimore : Johns Hopkins Hospital
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Baltimore : The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy
Baltimore : Sidney Kimmel Comprehensive Cancer Center
Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy
Baltimore : Call for Information (Investigational Site 0001)
Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)
Baltimore : Johns Hopkins University
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Bethesda : Research Site
A Phase I, Multicenter Dose Escalation Study in Patients With Leukemia
Bethesda : Center for Cancer & Blood Disorders, PC
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Bethesda : Research Site
CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Bethesda : National Institutes of Health Clinical Center, 9000 Rockville Pike
Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia
Bethesda : TG Therapeutics Investigational Trial Site
Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Bethesda : Center for Cancer and Blood Disorders
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Bethesda : National Institutes of Health Clinical Center, 9000 Rockville Pike
To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
Bethesda : TG Therapeutics Investigational Trial Site
Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies
Columbia : Maryland Oncology Hematology Pa
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Cumberland : Western Maryland Health System, Inc.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Rockville : Updated
An Extension Study of RO5045337 in Patients Participating in Previous Cancer Studies
Westminster : Alliance Hematology Oncology, PA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Massachusetts
Boston : Dana-Farber Cancer Institute
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Boston : Dana-Farber Cancer Institute
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Boston : Dana Farber Cancer Institute Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Boston : Investigational Site Number 840004
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Boston :
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma
View More »
Boston : Dana Farber Cancer Institute Deptof DanaFarberCancerInst(4)
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
Boston : Dana-Farber Cancer Institute
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Boston : Tufts University School of Medicine-Tufts Medical Center
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Boston : Beth Israel Deaconess Medical Center
Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)
Boston : Beth Israel Deaconess Medical Center
Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission
Boston : Dana-Farber Cancer Institute
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Boston : Research Site
CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Boston : Dana Farber Institute
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Boston : Dana Farber Cancer Institute and Children's Hospital
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Boston : Dana Farber Cancer Institute
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Boston : Beth Israel Deaconess Medical Center
Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Boston : Dana-Farber Cancer Institute
Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Boston : Massachusetts General Hospital
Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Boston :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Boston : Dana Farber Cancer Institute
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Boston : Dana-Farber Cancer Institute
Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL
Boston : Dana Farber Cancer Institute
MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
Boston : Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Boston : Dana Farber Cancer Institute
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Boston : Dana Farber Cancer Institute
Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Boston : Dana Farber Cancer Institute, Site #008
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Boston : Dana-Farber Cancer Institute
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Boston : Beth Israel Deaconess Medical Center
Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant
Boston : Massachusetts General Hospital
Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant
Boston : Dana Farber Cancer Institute Ctr. for Hematologic Oncology
Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
Boston : Research Site
Safety and Tolerability of AZD1208 and the Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients
Boston : Dana-Farber Cancer Institute
Safety Study of Anti-Programmed Death-1 in Hematologic Malignancy
Boston : Pfizer Investigational Site
Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia
Boston : Brigham & Women's Hospital
Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia
Boston : Dana Farber Cancer Institute
Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia
Boston : Beth Israel Deaconess Medical Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Boston : Dana-Farber Cancer Institute
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Boston : Massachusetts General Hospital
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Boston : Dana Farber Cancer Institute
Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Boston : Boston VA Healthcare System
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Boston : Massachusetts General Hospital
Treatment of Older Adults With Acute Lymphoblastic Leukemia
Boston : Beth Israel Deaconess Medical Center
Treatment of Older Adults With Acute Lymphoblastic Leukemia
Boston : Dana-Farber Cancer Institute
Treatment of Older Adults With Acute Lymphoblastic Leukemia
Boston : Dana Farber
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Hyannis : Capecod Hospital / Davenport Mugar Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Quincy : Commonwealth Hematology-Oncology, P.C.
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Wocester :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Worcester :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Worcester : Fallon Clinic
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Worcester : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Worcester : University of Massachusetts Memorial Medical Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Michigan
Ann Arbor :
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma
Ann Arbor : University of Michigan Comprehensive Cancer Center
MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
Ann Arbor : University of Michigan
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Ann Arbor : University of Michigan Cancer Center
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Ann Arbor : University of Michigan Comprehensive Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
View More »
Ann Arbor : University of Michigan
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Ann Arbor : C.S. Mott Children's Hospital
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Battle Creek :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Detroit : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Detroit : Barbara Ann Karmanos Cancer Institute
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Detroit : Karmanos Cancer Institute
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Detroit : Karmanos Cancer Institute
A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Detroit : Karmanos Cancer Institute
A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
Detroit : Henry Ford Health System
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Detroit : Pfizer Investigational Site
A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Detroit : Barbara Ann Karmanos Cancer Institute
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Detroit : Children's Hospital of Michigan
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Detroit : Henry Ford Hospital
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Detroit : Children's Hospital of Michigan
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Detroit : Children'S Hospital Of Michigan
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Detroit : Pfizer Investigational Site
Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia
Detroit : Henry Ford Health System
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Farmington Hills : Pfizer Investigational Site
Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia
Flint : Michigan State University / McLaren Regional Medical Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Flint : Genesee Cancer & Blood Disease Treatment Center, PC
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Freesoil : West Michigan Regional Cancer & Blood Center
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Grand Rapids : Cancer and Hematology Centers of Western Michigan
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Grand Rapids : Spectrum Health Hospitals
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Kalamazoo : West Michigan Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Kalamazoo : West Michigan Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Lansing : Michigan State University
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Minneapolis : University of Minnesota Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Southfield : Providence Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Minnesota
Duluth : Duluth Clinic Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Minneapolis : University of Minnesota
A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
Minneapolis : Minnesota Oncology Hematology, PA
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Minneapolis : University of Minnesota
A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)
Minneapolis : Children's Hospital and Clinics of Minnesota Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
View More »
Minneapolis : University of Minnesota
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Minneapolis : Minnesota Oncology Hematology P.A.
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Minneapolis : Novartis Investigative Site
Safety and Tolerability of HSC835 in Patients With Hematological Malignancies
Minneapolis : University of Minnesota: Masonic Cancer Center, BMT Clinic, and Fairview Medical Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Minneapolis : University of Minnesota
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Minneapolis : Childrens Hospital & Clinics of Minnesota
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Minneapolis : University of Minnesota Children's Hospital
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Rochester : Mayo Clinic
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Rochester : Mayo Clinic
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Rochester : Mayo Clinic
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Rochester : Mayo Clinic
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Rochester : Mayo Clinic
Clinical Study of PM01183 in Patients With Acute Leukemia
Rochester : Mayo Clinic
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Rochester :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Rochester : Mayo Clinic
Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients
Rochester : Mayo Clinic
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
St. Louis Park : Park Nicollet Institute Metro - MN CCOP
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
St. Louis Park : Park Nicollet Institute - Louisiana Ave.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Mississippi
Jackson : University of Mississippi Medical Center
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Jackson : Univ Of Mississippi Med Ctr
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Southaven : US Oncology - University of Tennessee Cancer Institute - Southaven
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Missouri
Branson : Branson Oncology Clinic
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Columbia : US Oncology - Missouri Cancer Associates
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Columbia : Ellis Fischel Cancer Center, University of Missouri Health Care
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Jefferson City : Capitol Comprehensive Cancer Care Clinic
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Kansas City : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
View More »
Kansas City : Saint Luke's Cancer Institute
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Kansas City : The Children'S Mercy Hospital And Clinics
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Saint Louis : Pfizer Investigational Site
A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Springfield : St. John's Medical Research Institute
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Springfield : Mercy Clinic - Cancer & Hematology, Site #151
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Springfield : St John's Clinic for Cancer and Hematology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
St Louis : Investigational Site Number 840015
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
St Louis : Washington University at St Louis
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
St. Joseph : St. Joseph Oncology, Inc.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
St. Louis : Washington University School of Medicine
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
St. Louis : (100) Washington University School of Medicine
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
St. Louis :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
St. Louis : St. Louis University Cancer Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
St. Louis : Washington University School of Medicine
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
St. Louis : 1315.1.1004 Boehringer Ingelheim Investigational Site
BI 836858 Dose Escalation in Refractory or Relapsed Acute Myeloid Leukemia
St. Louis : Washington University School of Medicine
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
St. Louis : St. Louis University Cancer Center
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
St. Louis : Hematology Oncology Consultants, Inc.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
St. Louis : St. Louis Hematology Oncology Specialists, Inc.
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
St. Louis : Washington University, St. Louis Children's Hospital
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
St. Louis : Washington University Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
St. Louis : Washington University
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
St. Louis : Washington University School of Medicine
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
St. Louis : Washington University Medical School
TK008: Efficacy Study on the Strategy of Herpes Simplex Virus Thymidine Kinase Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia
Montana
Billings : Call for Information (Investigational Site 0003) Updated
A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714 AM2)
Billings : (150) Billings Clinic
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
Billings : Billings Clinic
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Missoula : Montana Cancer Institute Foundation
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Nebraska
Lincoln : Nebraska Hematology Oncology, PC
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Lincoln : Southeast Nebraska Hematology & Oncology Consultants, PC
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Lincoln : Nebraska Hematology-Oncology, P.C., Site # 133
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Omaha : Nebraska Medical Center
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Omaha : University of Nebraska Medical Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
View More »
Omaha : University of Nebraska Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Omaha : University of Nebraska Medical Center
Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
Omaha : University of Nebraska Medical Center University of Nebraska Med Ctr
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Omaha : University of Nebraska Medical Center
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Omaha : University of Nebraska Medical Center
Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma
Omaha : Omaha VAMC
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Nevada
Carson City : Sierra Nevada Oncology Care
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Henderson : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Las Vegas : Southern Nevada Cancer Research Foundation
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Las Vegas : Nevada Cancer Center
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Las Vegas : Children'S Specialty Center Of Nevada
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
View More »
Las Vegas : US Oncology - Comprehensive Cancer Center of Nevada, Site #169
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Reno : VA Sierra Nevada Healthcare System
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
New Hampshire
Lebanon :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Lebanon : Investigational Site Number 840017
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Lebanon : Dartmouth - Hitchcock Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Lebanon : Dartmouth-Hitchcock Medical Center
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Portsmouth : Portsmouth Regional Hospital
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New Jersey
Cherry Hill : The Center for Cancer and Hematologic Disease
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Cherry Hill : The Center for Cancer and Hematologic Disease
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Denville : Cancer Care at Saint Clare's/Saint Clares Hospital Oncology & Hematology Specialists, P.A.
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
Elizabeth : Ellioth Fishkin, MD
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Englewood : Drs. Forte, Schleider, Attas & Condemi, PA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
View More »
Hackensack : Hackensack University Medical Center
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Hackensack : John Theurer Cancer Center at Hackensack University Med Center
A Multicenter Phase 2 Study of PCI-32765 (Ibrutinib) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion
Hackensack : Call for Information (Investigational Site 0007) Updated
A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714 AM2)
Hackensack : Hackensack University Medical Center
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Hackensack : Hackensack University Medical Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Hackensack : Hackensack University Medical Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Hackensack :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Hackensack : John Theurer Cancer Center at the Hackensack University Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Hackensack :
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma
Hackensack : Pfizer Investigational Site
A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Hackensack : Hackensack University Medical Center
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Hackensack : Research Site Updated
AMG 319 Lymphoid Malignancy FIH
Hackensack : Hackensack University Medical Center
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Hackensack : Hackensack University Medical Center Dept.of HackensackUniv.MedCtr.
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Hackensack : The Cancer Center at Hackensack University Medical Center
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Hackensack : Hackensack University Medical Center
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Hackensack : Hackensack University Medical Center
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Hackensack : Hackensack University Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Hackensack : John Theurer Cancer Center at HackensackUMC
Phase II Clinical Protocol for the Treatment of Patients With Previously Untreated CLL With Four or Six Cycles of Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide Followed by Lenalidomide Consolidation/ Maintenance
Hackensack : John Theurer Cancer Center, Site #128
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Hackensack : Hackensack University Medical Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Hackensack : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Hackensack : John Theurer Cancer Center
Safety Study of Anti-Programmed Death-1 in Hematologic Malignancy
Hackensack : John Theurer Cancer Center at Hackensack University Medical Center
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Hackensack : Hackensack University Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Morristown : Hematology Oncology Associates of Northern New Jersey
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Morristown : Hematology Oncology Associates of Northern New Jersey
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Morristown : Hematology Oncology Associates of Northern New Jersey
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Morristown : Charles Farber, MD
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Morristown : Hematology Oncology of Northern New Jersey
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Morristown : Goryeb Children'S Hospital
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Morristown : TG Therapeutics Investigational Trial Site
Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Morristown : Hematology-Oncology Associates of Northern NJ, PA
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New Brunswick : UMDNJ/Robert Wood Johnson Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
New Brunswick : Investigational Site Number 840001
Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia
Paterson : St. Joseph'S Regional Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Somerville : Steeplechase Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Summit : Overlook Hospital
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Vineland : Southern Oncology Hematology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New York
Albany : New York Oncology Hematology, P.C.
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Albany : Samuel S Stratton VAMC
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Bay Shore : Hematology Oncology Associates of Western Suffolk
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Bronx : Children's Hospital at Montefiore
A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer
Bronx : Montifiore Medical Center Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
View More »
Bronx : Montefiore Medical Center
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Bronx : Eastchester Center for Cancer Care
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Bronx : Bronx River Medical Associates
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Bronx : Montefiore Medical Center
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Bronx : Albert Einstein College of Medicine
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Bronx : Montefiore Medical Center
Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia
Bronx : Montefiore Medical Center / AECOM
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Bronxville : Eduardo Saponara, MD
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Buffalo : Roswell Park Cancer Institute
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Buffalo : Roswell Park Cancer Institute
A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia
Buffalo :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Buffalo : Pfizer Investigational Site
A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Buffalo : Roswell Park Cancer Streets
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Buffalo : Jonah Cancer Care Center & ECMC
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Buffalo : Roswell Park Cancer Institiute
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Buffalo : Roswell Park Cancer Institute
Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)
Buffalo : Roswell Park Cancer Institute
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Buffalo : Roswell Park Cancer Institute
Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Buffalo : Roswell Park Cancer Institute
SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Buffalo : Roswell Park Cancer Institute
Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia
Dunkirk :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Hawthorne : Westchester Hematology Oncology Group, PC
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Hawthorne : New York Medical College
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Johnson City : Broome Oncology
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Johnson City : Broome Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Lake Success : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Lake Success : North Shore - LIJ Health System
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Lake Success : North Shore Long Island Jewish Health System
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Mount Kisco : Westchester Hematology Oncology Associates
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
New Hyde Park : Long Island Jewish Medical Center
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
New Hyde Park : CLL Research and Treatment Program
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
New Hyde Park : North Shore University Hospital
A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
New Hyde Park : Long Island Jewish Medical Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
New Hyde Park : Long Island Jewish Medical Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
New Hyde Park : Long Island Jewish Medical Center
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
New Hyde Park : Long Island Jewish medical Center
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
New Hyde Park :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
New Hyde Park : Long Island Jewish Medical Center
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
New Hyde Park : Long Island Jewish Medical Center
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
New York : Weill Cornell Medical College
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
New York : Memorial Sloan Kettering Cancer Center
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
New York : Memorial Sloan Kettering Cancer Center
A First-in-Human Phase 1 and Expanded Cohort Study of EPZ-5676 in Advanced Hematologic Malignancies, Including Acute Leukemia With Rearrangement of the MLL Gene
New York : Weill Cornell Medical College
A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)
New York : New York Presbyterian Hospital/ Cornell Medical Center
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
New York : Stephen D. Hassenfeld Children'S Center
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
New York : Memorial Sloan Kettering Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
New York : Weill Cornell Medical College
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
New York : (165) Mount Sinai Medical Center New York
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
New York : Mount Sinai Medical Center
A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
New York : Weill Cornell Medical College
A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
New York : Memorial Sloan Kettering Cancer Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
New York : Beth Israel Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
New York : Memorial-Sloan Kettering Cancer Center
A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)
New York : Memorial Sloan Kettering Cancer Center
Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
New York : Columbia Presbyterian Medical Center
Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL
New York : Weill Cornell Medical College
Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (THRiL) as Initial Treatment for Patients With CLL
New York : Memorial Sloan-Kettering Cancer Center
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
New York : Weill Medical College of Cornell
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
New York : Memorial Sloan-Kettering Cancer Center
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
New York : Weill Cornell Medical College
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
New York : 1315.1.1002 Boehringer Ingelheim Investigational Site
BI 836858 Dose Escalation in Refractory or Relapsed Acute Myeloid Leukemia
New York : Memorial Sloan Kettering
Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
New York : Weill Cornell Medical College
Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML)
New York : Mount Sinai School of Medicine & Mount Sinai Graduate School of biological Sciences
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
New York : Weill Cornell Medical College
Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)
New York : Columbia University Medical Center
Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL
New York : Columbia Presbyterian - Harlem
KW 0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)
New York : Columbia University Medical Center
Lenalidomide in HTLV-1 Adult T-Cell Leukemia
New York : Columbia University - The Morgan Stanley Children's Hospital of New York
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
New York : Mount Sinai School of Medicine
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
New York : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
New York : Memorial Sloan-Kettering Cancer Center
Palifermin With or Without Leuprolide Acetate Versus Control for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
New York : New York Presby Hospital, Weill Medical College at Cornell University
Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
New York : Weill Cornell Medical College
Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies
New York : Cornell U, Weill Medical College
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
New York : Memorial Sloan-Kettering Cancer Center, Site #078
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
New York : Memorial Sloan-Kettering Cancer Center
Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome
New York : Mount Sinai Medical Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
New York : Weill Cornell Medical College
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
New York : Memorial Sloan Kettering Cancer Ctr
Safety Study of Anti-Programmed Death-1 in Hematologic Malignancy
New York : Cornell University
SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
New York : TG Therapeutics Investigational Trial Site
Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
New York : Memorial Sloan-Kettering Cancer Center
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
New York : Weill Cornell Medical College
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
New York : Memorial Sloan Kettering Cancer Center
Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
New York : Weill Medical College of Cornell
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
New York : Advanced Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New York : St. Lukes Roosevelt Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New York : Memorial Sloan Kettering Cancer Center
Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies
New York : Children's Hospital New York-Presbyterian
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
New York City : Columbia Presbyterian Medical Center Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
New York City : New York Hospital Weill Cornell Medical Center
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
Rochester : Univ. of Rochester Cancer Center
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Rochester : U of Rochester Medical Ct James P Wilmot Cancer Ctr
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Rochester : University of Rochester Medical Center
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Rochester : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Stony Brook : Stony Brook University Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Stony Brook : Research Site
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders
Stony Brook : Stony Brook University Medical Center
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Stony Brook : Stony Brook University Hospital
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Syracuse : SUNY Upstate Medical University
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Syracuse : SUNY Upstate Medical University - Adult Program
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Syracuse : Suny Upstate Medical University
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Syracuse : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Valhalla : Investigational Site Number 840009
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Valhalla :
A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
Valhalla : New York Medical College
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Valhalla : New York Medical College
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Valhalla : New York Medical College, Division of Oncology/Hematology
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
North Carolina
Cary : US Oncology - Cancer Centers of North Carolina - Cary
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Cary : Waverly Hematology Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Chapel Hill : University of North Carolina at Chapel Hill - Lineberger Comprehensive Cancer Center
Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard Induction
Chapel Hill : University of North Carolina at Chapel Hill
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Chapel Hill : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
View More »
Chapel Hill : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Chapel Hill : University of North Carolina Hospitals
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Charlotte : Levine Children's Hospital
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Charlotte :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Charlotte : Levine Children'S Hospital
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Charlotte : Mecklenburg Medical Group
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Charlotte : Levine Children's Hospital at Carolinas Medical Center
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Durham : Duke University Medical Center
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Durham : Duke University Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Durham : Research Site Updated
AMG 319 Lymphoid Malignancy FIH
Durham : Duke University Medical Center Duke University Med Ctr
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Durham : Duke University Medical Center
Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)
Durham : Duke University Medical Center
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Durham : Duke University Medical Center
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Durham : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Durham : Duke University
SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Durham : Duke University Medical Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Durham : Duke University Medical Center
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Durham : Duke University Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Gastonia : Gaston Hematology Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Greenville : East Carolina University
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New Bern : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Raleigh : US Oncology - Cancer Centers of North Carolina - Falls
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Raleigh : US Oncology - Cancer Centers of North Carolina - Macon
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Raleigh : Rex Cancer Center
Telemonitoring Study - for Chronic Myeloid Leukemia (CML)
Raleigh : Rex Cancer Center - Wakefield
Telemonitoring Study - for Chronic Myeloid Leukemia (CML)
Winston-Salem : Wake Forest University
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Winston-Salem : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Winston-Salem : Wake Forest University Health Sciences
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
North Dakota
Bismarck :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Bismarck : Legacy Pharma Research
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Bismarck : Mid Dakota Clinic/Odyssey Research
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Fargo : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Fargo : Roger Maris Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Ohio
Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
A Feasibility Pilot and Phase 2 Study of Chemoimmunotherapy with Epratuzumab for Children with Relapsed CD22-Positive Acute Lymphoblastic Leukemia
Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
ADVL0816: A Phase I Study of Obatoclax (Pan Anti-Apoptotic BCL-2 Family Small Molecule Inhibitor), in Combination with Vincristine/Doxorubicin/Dexrazoxane, in Children with Relapsed/Refractory Solid Tumors or Leukemia
View More »
Akron : Summa Health System - Cancer Research Office
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Akron : Summa Health System Hospitals
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Akron : Akron General Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Canton : Call for Information (Investigational Site 0035) Updated
A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714 AM2)
Canton : Investigational Site Number 840014
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Canton : Gabrail Cancer Center Research
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Canton : Gabrail Cancer Center
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Canton : Gabrail Cancer Center Research
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Canton : Nashat Y. Gabrail, MD, Inc.
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Cincinnati : Cincinnati Children's Hospital Medical Center Cincinnati Children's Hosp
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Cincinnati : The Christ Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Cincinnati : Cincinnati Children's Hospital Medical Center
Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Cincinnati : Cincinnati Children'S Hospital Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Cleveland : Cleveland Clinic
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Cleveland : Cleveland Clinic Foundation
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Cleveland : Case Western Reserve University Hospitals of Cleveland
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Cleveland : University Hospitals Case Medical Center
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Cleveland : Cleveland Clinic
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Cleveland : University Hospitals of Cleveland
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Cleveland : Cleveland Clinic Taussig Cancer Center
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
Cleveland : Cleveland Clinic - Taussig Cancer Institute
Phase 1/2 Study of Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)
Cleveland : Cleveland Clinic
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Cleveland : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Cleveland : Case Western Reserve University, University Hospitals of Cleveland
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Cleveland : Cleveland Clinic, Taussig Cancer Institute
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Cleveland : Cleveland Clinic
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Cleveland : University Hospitals Case Medical Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Cleveland : Pfizer Investigational Site
Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia
Cleveland : Research Site
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders
Cleveland : University Hospitals fo Cleveland
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Cleveland : University Hospitals Case Medical Center
Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission
Columbus : The Ohio State University
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Columbus : The Ohio State University Comprehensive Cancer Center
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Columbus : James Cancer Hospital
Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
Columbus : The Ohio State University Medical Center
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Columbus : 1315.1.1001 Boehringer Ingelheim Investigational Site
BI 836858 Dose Escalation in Refractory or Relapsed Acute Myeloid Leukemia
Columbus : Mid Ohio Oncology / Hematology, Inc.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Columbus :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Columbus : Nationwide Children'S Hospital
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Columbus : OSU
Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Columbus : For additional information regarding sites for this trial call (919) 465-4648
Phase 1b Safety and Efficacy Study of TRU-016 and Rituximab in Previously Untreated Chronic Lymphocytic Leukemia
Columbus : Ohio State Comprehensive Cancer Center/James Cancer Hospital Dept.ofJamesCancerHospital
Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
Columbus : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Columbus : Ohio State University
SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Columbus : Ohio State University Medical Center
Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)
Columbus : Nationwide Childrens Hospital
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Dayton : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Dayton : The Children'S Medical Center Of Dayton
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Elyria : Hematology Oncology Center, Inc.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Middletown : Signal Point Clinical Research Center, Site #139
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Middletown : Signal Point Clinical Research Center, LLC
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Newark : Medical Center of Newark
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Toledo : Mercy Children'S Hospital
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Oklahoma
Oklahoma City : University Of Oklahoma Health Sciences Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Oklahoma City : University of Oklahoma, Site #028
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Oklahoma City : University of Oklahoma Health Science Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Oklahoma City : University of Oklahoma Health Sciences Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Tulsa : Cancer Care Associates
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Oregon
Eugene : Willamette Valley Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Eugene : Willamette Valley Cancer and Research / USOR
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Eugene : US Oncology - Willamette Valley Cancer Institute - Eugene
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Portland : Call for Information (Investigational Site 0144) Updated
A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714 AM2)
Portland : Oregon Health & Sciences University
A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
View More »
Portland : Oregon Health & Sci Univ
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Portland : Northwest Cancer Specialists, PC
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Portland : Oregon Health and Science University
A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia
Portland : Oregon Health & Sciences Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Portland :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Portland :
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma
Portland : Oregon Health & Science University
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Portland : Oregon Health & Science University
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Portland : US Oncology - Northwest Cancer Specialists, PC - Portland - Broadway
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Portland : US Oncology - Northwest Cancer Specialists, PC - Portland - Hoyt
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Portland : US Oncology - Northwest Cancer Specialists, PC - Portland - Barnes
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Portland : Oregon Health & Sciences University - Doerbecher Children's
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Portland : Oregon Health & Science University Dept. Hematologic Malignancies
Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy
Portland : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Portland : Legacy Emanuel Hospital & Health Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Portland : Oregon Health & Science University
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Portland : Oregon Health & Science University
Validation of an in Vitro Assay to Predict Targeted Therapies for Acute Leukemia Patients
Salem : Hematology/Oncology Salem LLP
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Springfield : Willamette Valley Cancer Center
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Springfield : Willamette Valley Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Springfield : Willamette Valley Cancer Institute and Research Center
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Springfield : US Oncology - Willamette Valley Cancer Institute - Springfield
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Springfield : US Oncology Research: Willamette Valley Cancer Institute and Research Center
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Springfield : Willamette Valley Cancer Institute and Research Center
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Tualatin : Northwest Cancer Specialists, PC
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Tualatin : Northwest Cancer Specialists, PC
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Tualatin : Northwest Cancer Specialists, P.C.
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Tualatin : US Oncology - Northwest Cancer Specialists, PC - Tualatin
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Pennsylvania
Abington : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Bethlehem : Oncology Hematology of Lehigh Valley
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Danville : Geisinger Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Drexel Hill : Consultants in Medical Oncology and Hematology, PC
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Gettysburg : Gettysburg Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
View More »
Harrisburg : Andrews and Patel Associates
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Hershey : Penn State Milton S. Hershey Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Hershey : Penn State Milton S. Hershey Medical Center
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Hershey : Penn State Milton S. Hershey Medical Center
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Hershey : Penn State Milton S. Hershey Medical Center
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Hershey : Penn State Hershey Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Hershey : Penn State Hershey Cancer Institute
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Kingston : US Oncology - Medical Oncology Associates (Nahar)
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Kingston : Medical Oncology Associates of Wyoming Valley, PC
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Lancaster : Lancaster Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Lancaster : Lancaster General Health
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Norristown : Luitpold Pharmaceuticals, Inc.
Bioequivalence Trial of Luitpold Azacitidine Versus Vidaza® in Patients With Myelodysplastic Syndrome, Myelofibrosis, Chronic Myeloid Leukemia or Chronic Lymphocytic Leukemia
Philadelphia : Children's Hospital of Philadelphia Pediatric Oncology Clinic
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Philadelphia : University of Pennsylvania, Abramson Cancer Center
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Philadelphia : Children'S Hospital Of Philadelphia
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Philadelphia : Fox Chase Cancer Center
A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
Philadelphia : Investigational Site Number 840001
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Philadelphia : Abramson Cancer Center of the University of Pennsylvania
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Philadelphia :
A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
Philadelphia : Hospital of the University of Pennsylvania
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Philadelphia : University of Pennsylvania
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Philadelphia : Children's Hospital of Philadelphia
Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Philadelphia : Thomas Jefferson University
Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma
Philadelphia : Hospital of the University of Pennsylvania
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Philadelphia : Thomas Jefferson University
Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)
Philadelphia : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Philadelphia : Children'S Hospital Of Philadelphia
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Philadelphia : University of Pennsylvania, Abramson Cancer Center
Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Philadelphia : University of Pennsylvania Health System
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Philadelphia : Abramson Cancer Center of the University at Perlman Center for Advanced Medicine
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Philadelphia : Thomas Jefferson University
Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias
Philadelphia : Abramson Cancer Center of the University of Pennsylvania
Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission
Pittsburgh : Western Pennsylvania Hospital
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Pittsburgh : Children'S Hospital Of Pittsburgh
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Pittsburgh : (160) The Western Pennsylvania Hospital- Cancer Institute
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
Pittsburgh : Children's Hospital of Pittsburgh Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Pittsburgh : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Pittsburgh : Children'S Hospital Of Pittsburgh Of Upmc
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Pittsburgh : UPMC
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Pittsburgh : The Western Pennsylvania Hospital
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Pittsburgh : Veterans Research Foundation of Pittsburgh
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Reading : Berks Hematology Oncology Associates
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Sayre : Call for Information (Investigational Site 0048) Updated
A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714 AM2)
Wilkes Barre : Geisinger Health System
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Willow Grove : Abington Hematology Oncology Associates
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
York : Cancer Care Association Of York
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Rhode Island
Cranston : Hematology & Oncology Associates of Rhode Island
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Cranston : Sambandam and Joseph Associates, Inc
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Cranston : Hematology and Oncology Associates of RI
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
South Carolina
Charleston : Charleston Hematology Oncology
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Charleston :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Charleston : Medical University of South Carolina, Hollings Cancer Center
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Charleston : Charleston Hematology Oncology Associates, PA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Charleston : Charleston Hematology Oncology, PA
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
View More »
Charleston : Medical University of South Carolina
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Charleston : Medical University of South Carolina
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Charleston : Medical University of South Carolina MUSC/HCC (2)
Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
Charleston : Investigational Site Number 840002
Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia
Charleston : Medical University of South Carolina
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Charleston : Charleston Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Charleston : Medical University of South Carolina
Trial of Intracycle Sequential Ofatumumab and Lenalidomide for the Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab
Columbia : Liberty Hematology Oncology
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Columbia : South Carolina Oncololgy Associates, PA
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Columbia : South Carolina Oncology Associates
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Easley : US Oncology - Cancer Centers of the Carolinas - Easley
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Greenville : Cancer Centers of the Carolinas
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Greenville : Cancer Centers of the Carolinas CCC Greenville
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Greenville : Cancer Centers of the Carolinas
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Greenville : Saint Francis Hospital
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Greenville : Cancer Centers of the Carolinas Cancer Center
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Greenville : US Oncology - Cancer Centers of the Carlinas - Eastside
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Greenville : US Oncology - Cancer Centers of the Carolinas - Butternut
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Greenville : US Oncology - Cancer Centers of the Carolinas - West Faris
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Greenville : Bon Secours St. Francois Health System
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Greenville : Greenville Hospital System
Trial of Intracycle Sequential Ofatumumab and Lenalidomide for the Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab
Seneca : US Oncology - Cancer Centers of the Carolinas - Seneca
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Spartanburg : US Oncology - Cancer Centers of the Carolinas - Spartanburg
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Sumter : Carolina Hematology Oncology, Site #143
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
South Dakota
Sioux Falls : (120) Avera Cancer Institute
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
Sioux Falls : Sanford Clinic
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Sioux Falls : Avera Research Institute
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Watertown : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Watertown : Prairie Lakes Healthcare System, Inc
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Tennessee
Bartlett : US Oncology - University of Tennessee Cancer Institute - Bartlett
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Chattanooga : Chattanooga Oncology and Hematology Assoicates, PC Memorial Plaza
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Collierville : Family Cancer Center, PLLC
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Collierville : The Family Cancer Center
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Germantown : The Jones Clinic
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
View More »
Germantown : US Oncology - University of Tennessee Cancer Institute - Germantown
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Germantown : C. Michael Jones, MD, PC
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Knoxville : East Tennessee Children'S Hosp
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Knoxville : Tennessee Cancer Specialists
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Memphis : Research Site
CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Memphis : St Jude Children's Research Hospital
Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Memphis : St. Jude Children's Research Hospital
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Memphis : US Oncology - University of Tennessee Cancer Institute - Memphis
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Memphis : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Memphis : The West Clinic Updated
Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Memphis : Family Cancer Center
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Memphis : St. Jude
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Nashville : Sarah Cannon Cancer Center
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Nashville : Vanderbilt-Ingram
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Nashville : Sarah Cannon Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Nashville : (230) Tennessee Oncology, PLLC
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
Nashville : Sarah Cannon Research Institute
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Nashville :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Nashville : Vanderbilt University Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Nashville : Pfizer Investigational Site
A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Nashville : Sarah Cannon Research Institute
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Nashville : Vanderbilt University, Vanderbilt Ingram Cancer Center
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Nashville : Tennessee Oncology Dept. of Centennial Medical
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Nashville : SCRI
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Nashville : Vanderbilt U Medical Center
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Nashville : TG Therapeutics Trial Site
Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic Malignancies
Nashville : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Nashville : Vanderbuilt University
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Nashville : SCRI
Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Nashville : Tennessee Oncology, Pllc
Phase IIb Study of Dasatinib Versus Imatinib in Patients With CML-CP Who Have Not Achieved an Early Optimal Response to Imatinib
Nashville : Vanderbilt University
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Nashville : Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt 3
Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
Nashville : Tennessee Oncology, PLLC
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Nashville : Henry-Joyce Cancer Clinic
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Nashville : Sarah Cannon Research Institute
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Nashville : Vanderbilt University
Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission
Nashville : Vanderbilt Children's Hospital
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Texas
Abilene : US Oncology - Texas Cancer Center - Abilene (South)
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Amarillo : US Oncology - Texas Oncology, PA - Amarillo
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Amarillo : Texas Oncology
Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
Amarillo : Texas Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Arlington : US Oncology - Texas Oncology - Arlington South
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
View More »
Arlington : Texas Oncology - Arlington South
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Austin : Texas Oncology
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Austin : Dell Children'S Medical Center Of Central Texas
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Austin : US Oncology - Texas Oncology Austin, Site #172
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Austin : Texas Oncology-Austin North
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Beaumont : Julie & Ben Rogers Cancer Institute
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Bedford : Texas Oncology - Bedford
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Bedford : US Oncology - Texas Oncology, PA - Bedford
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Bryan : St. Joseph Regional Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
College Station : Scott & White Clinic
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Corpus Christi : South Texas Institute of Cancer
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Corpus Christi : Coastal Bend Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Corpus Christi : Driscoll Children'S Hospital
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Dallas : Texas Oncology PA
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Dallas : (105) University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia in Elderly Subjects ≥ 65 Years of Age
Dallas : Baylor Charles A. Sammons Cancer Center at Dallas
A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Dallas : Mary Crowley Cancer Research Centers - Medical City
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Dallas : Baylor University Medical Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Dallas : UT Southwestern Medical Center
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Dallas : UT Southwestern Medical Center, Simmons Cancer Center
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Dallas : Texas Oncology - Dallas Presbyterian
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Dallas : Texas Oncology - Medical City Dallas
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Dallas : UT Southwestern Medical Center
Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Dallas : Baylor Research Institute Baylor Research Institute (17)
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Dallas : US Oncology - Texas Oncology, PA - Dallas
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Dallas :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Dallas : Ut Southwestern
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Dallas : University of Texas Southwestern Medical Center
Phase II Study of Crenolanib in Subjects With Relapsed AML With FLT3-D835 Activating Mutations
Dallas : US Oncology - Texas Oncology Dallas, Site #171
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Dallas : University of Texas Southwestern Medical Center at Dallas
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Dallas : University of Texas Southwestern Medical Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Dallas : UT Southwestern Medical Center at Dallas
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Dallas : Texas Oncology-Dallas Presbyterian Hospital
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Dallas : Texas Oncology-Medical City Dallas
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Dallas : Texas Oncology-Methodist Charlton Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
El Paso : US Oncology - El Paso Cancer Treatment Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
El Paso : US Oncology - El Paso Cancer Treatment Center - West
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Fort Worth : Texas Oncology, P.A.
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Fort Worth : Texas Oncology, P.A.
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Fort Worth : Texas Oncology, P.A.
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Fort Worth : Texas Oncology - Fort Worth 12th Avenue
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Fort Worth : Cook's Children's Medical Center
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Fort Worth : US Oncology - Texas Oncology, PA - Fort Worth
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Fort Worth : US Oncology - Southwest Fort Worth Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Fort Worth : JPS Center for Cancer Care
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Fort Worth : Cook Children'S Medical Center
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Grapevine : US Oncology - Texas Oncology - Grapevine
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Houston : UT MD Anderson Cancer Center
2CDA With Rituximab in Hairy Cell Leukemia
Houston : UT MD Anderson Cancer Center
5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Houston : MD Anderson Cancer Center
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Houston : MD Anderson Cancer Center
A Phase II Study of Crenolanib in Relapsed/Refractory Acute Myeloid Leukemia Patients With FLT3 Activating Mutations
Houston : Md Anderson Cancer Center
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Houston : Texas Children'S Cancer Center
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Houston : M.D. Anderson Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Houston : M.D. Anderson Cancer Center
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Houston : M.D. Anderson Cancer Center
A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)
Houston : MD Anderson Cancer Center
A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
Houston : Texas Children's Hospital Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Houston :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Houston : Pfizer Investigational Site
A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia
Houston : MD Anderson Cancer Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Houston : M.D. Anderson Cancer Center
A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)
Houston : Pfizer Investigational Site
A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Houston : Site Reference ID/Investigator# 26522
ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies
Houston : UT MD Anderson Cancer Center Updated
Acute Promyelocytic Leukemia (APL) Treated With ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin
Houston : MD Anderson Cancer Center
A-dmDT390-bisFv (UCHT1) Immunotoxin Therapy for Patients With T-cell Diseases
Houston : MD Anderson Cancer Center
ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia
Houston : MD Anderson Cancer and Research Center
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Houston : MD Anderson Cancer Center
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Houston : MD Anderson
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Houston : UT MD Anderson Cancer Center
Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)
Houston : MD Anderson Cancer Center / University of Texas
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Houston : M D Anderson Cancer Center
Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
Houston : University of Texas MD Anderson Cancer Center
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Houston : Texas Children's Cancer Center/ Baylor
Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Houston : UT MD Anderson Cancer Center Updated
CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies
Houston : Northwest Cancer Center
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Houston : UT MD Anderson Cancer Center
Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)
Houston : UT MD Anderson Cancer Center
Combination Study of Cytarabine and Tosedostat in Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndromes (MDS)
Houston : Oncology Consultants
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Houston : MD Anderson Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Houston : UT MD Anderson Cancer Center
E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes
Houston : The University of Texas MD Anderson Cancer Center
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Houston : UT MD Anderson Cancer Center
Eltrombopag for Management of Thrombocytopenia
Houston : University of Texas MD Anderson Cancer Center
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Houston : The University Of Texas Md Anderson Cancer Center
First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
Houston : UT MD Anderson Cancer Center
Fludarabine, Bendamustine and Rituximab Conditioning for Patients With Lymphoid Malignancies
Houston : UT MD Anderson Cancer Center
Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations
Houston : UT MD Anderson Cancer Center
Hyper CVAD Plus Ofatumumab in CD - 20 Positive Acute Lymphoblastic Leukemia (ALL)
Houston : UT MD Anderson Cancer Center Updated
Hyper-CVAD and Ponatinib in Ph-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL)
Houston : UT MD Anderson Cancer Center Updated
Inotuzumab Ozogamycin in Elderly Acute Lymphoblastic Leukemia (ALL)
Houston : UT MD Anderson Cancer Center
Low Dose Cytarabine and Lintuzumab-Ac225 in Older Patients
Houston : M. D. Anderson Cancer Center at University of Texas
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Houston : MD Anderson Cancer Center/University of Texas UT MD Anderson
Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy
Houston : UT MD Anderson Cancer Center
Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)
Houston : U.T. M.D. Anderson Cancer Center
Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy
Houston : UT MD Anderson Cancer Center
Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
Houston : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Houston : Baylor College Of Med/Tx Chldrns Cancer & Hem Ctrs.
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Houston : UT MD Anderson Cancer Center
Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies
Houston : The University of Texas MD Anderson Cancer Center
Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients
Houston : UT MD Anderson Cancer Center
Phase I/II - Dasatinib and Decitabine
Houston : MD Anderson Cancer Center
Phase I/II Study of DFP-10917 in Patients With Acute Leukemia
Houston : UT MD Anderson Cancer Center
Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)
Houston : UT MD Anderson Cancer Center
Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML)
Houston : UT MD Anderson Cancer Center Updated
Phase II Study of Ofatumumab in Elderly Patients With Chronic Lymphocytic Leukemia (CLL)
Houston : M.D. Anderson Cancer Center
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Houston : UT MD Anderson Cancer Center Updated
Pilot Study to Determine Effects of the Btk Inhibitor PCI-32765 on Leukemia Cell Kinetics and Trafficking, Using Heavy Water Labeling in Subjects With CLL and SLL
Houston : UT MD Anderson Cancer Center
PKC412 and 5-Azacytidine
Houston : UT MD Anderson Cancer Center
Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)
Houston : UT MD Anderson Cancer Center
Ponatinib - 2nd Line Therapy
Houston : UT MD Anderson Cancer Center
Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)
Houston : UT MD Anderson Cancer Center
RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia
Houston : University of Texas M. D. Anderson Cancer Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Houston : UT MD Anderson Cancer Center
Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2
Houston : University of Texas, MD Anderson Cancer Center
Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma
Houston : University of Texas M.D. Anderson Cancer Center
Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies
Houston : Research Site
Safety and Tolerability of AZD1208 and the Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients
Houston : UT MD Anderson Cancer Center
Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)
Houston : Investigational Site Number 840001
SAR3419 in Acute Lymphoblastic Leukemia
Houston : MD Anderson Cancer Center
SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Houston : Investigational Site Number 840003
Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia
Houston : Research Site
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders
Houston : UT MD Anderson Cancer Center
Study of Dasatinib in Patients With Chronic Myelogenous Leukemia
Houston : University of Texas M.D. Anderson Cancer Center
Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias
Houston : MD Anderson Cancer Center
Study of KB004 in Subjects With Hematologic Malignancies
Houston : MD Anderson Cancer Center
Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia
Houston : Call for Information (Investigational Site 0002)
Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)
Houston : The University of Texas, M.D. Anderson Cancer Center, Department of Leukemia
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Houston : UT MD Anderson Cancer Center
Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced Leukemias
Houston : The University Of Texas Md Anderson Cancer Center
Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Houston : MD Anderson Cancer
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Houston : MD Anderson Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Houston : Michael DeBakey VA Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Houston : MD Anderson Cancer Center
TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation
Houston : UT MD Anderson Cancer
Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Houston : UT MD Anderson Cancer Center
Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)
Houston, : M.D. Anderson Cancer Center
Clinical Study of PM01183 in Patients With Acute Leukemia
Houston, Texas : The University of Texas, M.D. Anderson Cancer Center
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Kerrville : US Oncology - San Antonio Tumor & Blood Clinic - Kerrville
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Lackland AFB : Wilford Hall Medical Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Laredo : South Texas Research Alliance LLC Updated
A Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 Versus Chlorambucil in Patients 65 Years or Older With Treatment-naive Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (RESONATE™-2)
Laredo : South Texas Research Alliance, LLC
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Laredo : South Texas Research Alliance LLC Updated
An Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Who Participated in Study PCYC-1115-CA (PCI-32765 Versus Chlorambucil)
Lewisville : Texas Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Longview : US Oncology - Longview Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Lubbock : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Lubbock : Joe Arrington Cancer Research and Treatment Center
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Lubbock : Joe Arrington Cancer Research and Treatment Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
McAllen : US Oncology - Texas Oncology - McAllen
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
McAllen : Texas Oncology-McAllen South Second
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Mesquite : US Oncology - Texas Oncology - Mesquite
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Mesquite : Texas Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Midland : US Oncology - Allison Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Midland : US Oncology - Texas Oncology Midland, Site #173
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Midland : Texas Oncology-Midland Allison Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Odessa : Texas Oncology-Odessa West Texas Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Paris : US Oncology - Texas Oncology - Paris
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Paris : Texas Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Plano : North Texas Regional Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Round Rock : Texas Oncology - Central Austin Cancer Center
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Round Rock : Texas Oncology
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
San Antonio : Cancer Care Network of South Texas
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
San Antonio : Oncology of San Antonio Updated
A Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 Versus Chlorambucil in Patients 65 Years or Older With Treatment-naive Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (RESONATE™-2)
San Antonio : Cancer Care Centers of South Texas
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
San Antonio : Cancer Care Network of South Texas
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
San Antonio :
A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
San Antonio : Oncology of San Antonio Updated
An Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Who Participated in Study PCYC-1115-CA (PCI-32765 Versus Chlorambucil)
San Antonio : US Oncology - San Antonio Tumor & Blood Clinic - M. Oak
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
San Antonio : US Oncology - Cancer Care Centers of South Texas
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
San Antonio : University of Texas Health Science Center, San Antonio
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
San Antonio : Methodist Children's Hospital of South Texas/Texas Institute of Medicine and Surgery
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
San Antonio : US Oncology - Cancer Care Center of South Texas, Site #170
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
San Antonio : Cancer Care Centers of South Texas
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
San Antonio : Cancer Therapy Reasearch Center at UTHSCA
Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia
San Antonio : Texas Transplant Physician's Group
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
San Antonio : Cancer Care Centers of South Texas
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
San Antonio : Cancer Care Centers of South Texas
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Sherman : US Oncology - Texas Oncology - Sherman
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Temple : Call for Information (Investigational Site 0269) Updated
A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714 AM2)
Temple :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Temple : Scott and White Hospital and Clinic
A-dmDT390-bisFv (UCHT1) Immunotoxin Therapy for Patients With T-cell Diseases
Temple : Scott & White Healthcare Department of Research
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Temple : Scott & White Healthcare
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Tyler : ETMC dba Blood and Cancer Center - East Texas
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Tyler : US Oncology - Texas Oncology - Tyler
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Tyler : ETMC dba Tyler Hematology Oncology
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Tyler : Texas Oncology
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
Waco : Texas Oncology - Waco
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Waco : US Oncology - Texas Oncology Cancer Care and Research Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Waco : Texas Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Weslaco : US Oncology - Texas Oncology - Weslaco
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Wichita Falls : US Oncology - Texoma Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Utah
American Fork : Central Utah Clinic
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Logan : Cache Valley Cancer Treatment & Research Clinic, Inc.
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Ogden : Northern Utah Associates
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Salt Lake City : University of Utah
A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia
Salt Lake City : Huntsman Cancer Institute at the University of Utah
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
View More »
Salt Lake City : Research Site Updated
AMG 319 Lymphoid Malignancy FIH
Salt Lake City :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Salt Lake City : University of Utah - Primary Children's Medical Center
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Salt Lake City : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Salt Lake City : Huntsman Cancer Institute, Site #043
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Virginia
Abingdon : Cancer Outreach Associates, PC
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Arlington : US Oncology - Arlington Fairfax Hematology Oncology
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Charlottesville : Virginia University
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Charlottesville : University of Virginia Health System
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Charlottesville : University of Virginia
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
View More »
Christianburg : Oncology and Hematology Assoc of SW VA DBA Blue Ridge Cancer Care
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Christiansburg : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Christiansburg
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Fairfax : Virginia Cancer Specialists, PC
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Fairfax : Virginia Cancer Specialists, PC
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Fairfax : Virginia Cancer Specialists, PC
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Fairfax : US Oncology - Fairfax Northern VA Hem-Onc PC
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Falls Church : Inova Fairfax Medical Center Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Fredericksburg : Hematology Oncology Associates of Fredricksburg
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Gainesville : US Oncology - Fairfax - Northern Virginia Hematology-Oncology, PC - Gainesville
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Leesburg : US Oncology - Fairfax - Northern Virginia Hem-Onc, PC - Leesburg
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Low Moor : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Low Moor
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Newport News : Peninsula Cancer Institute
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Norfolk : Children'S Hosp-Kings Daughter
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Norfolk : Virginia Oncology Associates
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
Richlands : Virginia Oncology Care, PC
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Richmond : Virginia Commonwealth University
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Richmond : Massey Cancer Center/Virginia Commonwealth University
Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT
Roanoke : Oncology and Hematology Associates of Southwest Virginia, Inc.
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Roanoke : Oncology and Hematology Associates of Southwest Virginia, Inc
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Roanoke : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Roanoke
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Roanoke : Blue Ridge Cancer Care
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Salem : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Salem
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Winchester : US Oncology - Shenandoah Oncology - Winchester
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Woodbridge : US Oncology - Fairfax - Northern Virginia Hem-Onc, PC - Woodbridge
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Wytheville : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Wytheville
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Washington
Bellingham : Peace Health Medical Group
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Edmonds : Puget Sound Cancer Centers
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Edmonds : US Oncology - Puget Sound Cancer Center - Edmonds
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Everett : Providence Regional Cancer Partnership
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Everett : Providence Everett Medical Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
View More »
Kennewick : Columbia Basin Hematology and Oncology
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Seattle : Seattle Cancer Care Alliance
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Seattle : Fred Hutchinson Cancer Research Center
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Seattle : Seattle Cancer Care Alliance
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
Seattle : Seattle Children'S
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Seattle : Seattle Cancer Care Alliance
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Seattle : Seattle Cancer Care Alliance
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Seattle : Seattle Cancer Care Alliance
A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)
Seattle : Fred Hutchinson Cancer Research Center
A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
Seattle : Seattle Cancer Care Alliance
A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
Seattle :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Seattle : Seattle Children's Hospital CPKC412A2114
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
Seattle : Fred Hutchinson Cancer Research Center
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Seattle : US Oncology - Puget Sound Cancer Center - Seattle
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Seattle :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Seattle : Seattle Children's Hospital
Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL
Seattle : University Of Washington School Of Medicine
First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
Seattle : University of Washington
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Seattle : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Seattle : Fred Hutchinson Cancer Research Center
Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Seattle : Fred Hutchinson Cancer Research Center
Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients
Seattle : Fred Hutchinson Cancer Research Center
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Seattle : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Seattle : Pfizer Investigational Site
Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia
Seattle : Seattle Cancer Care Alliance
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
Seattle : Fred Hutchinson Cancer Research Center
Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Seattle : Seattle Children's Hospital
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Spokane : Cancer Care Northwest, US Oncology
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Spokane : US Oncology - Cancer Care Northwest - Holland
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Spokane : US Oncology - Cancer Care Northwest - Sherman
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Spokane : Medical Oncology Associates PS
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Spokane : US Oncology - Cancer Care Northwest - Mission
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Spokane : Providence Cancer Center at Sacred Heart Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Spokane Valley : Cancer Care Northwest
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Tacoma : Northwest Medical Specialties
A Randomized, Controlled Study Evaluating the Efficacy and Safety of GS-1101 (CAL-101) in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia
Vancouver : US Oncology - Northwest Cancer Specialists, PC - Vancouver - 136th St.
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Vancouver : US Oncology - Northwest Cancer Specialists, PC - Vancouver - 134th St
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Vancouver : US Oncology - Northwest Cancer Specialists, Site #174
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Walla Walla : Providence St. Mary Regional Cancer Center
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Wenatchee : Wenatchee Valley Medical Center
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Wenatchee : Wenatchee Valley Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Yakima : Yakima Valley Memorial Hospital/North Star Lodge
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Yakima : Yakima Valley Memorial Hospital
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Yakima : Yakima Valley Memorial Hospital / North Star Lodge
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Yakima : Yakima Regional Cancer Care
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Yakima : Yakima Valley Memorial Hospital / North Star Lodge
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Yakima : US Oncology - Yakima Valley Memorial Hospital/North Star Lodge (Boyd)
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Yakima : Yakima Valley Memorial Hospital/North Star Lodge
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
Yakima : North Star Lodge Cancer Center
Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
Yakima : Yakima Valley Memorial Hospital/North Star Lodge
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
West Virginia
Morgantown : West Virginia University - Clinical Trials Research Unit
CASE 1908: A Phase I/II Study of Midostaruin(PKC412) and 5-Azaacitidine for Elderly Patients with Acute Myelogenous Leukemia
Morgantown : West Virginia University - Clinical Trials Research Unit
E2906- Phase III trial of Clofarabine as induction and post-remission therapy vs. standard daunorubicin & cytarabine post-remission therapy, followed by decitabine maintenance vs. observation in newly-diagnosed Acute Myeloid Leukemia in older adults (age greater than or equal to 60 years)
Morgantown : West Virginia University - Clinical Trials Research Unit
S0535 - A Phase II Study of ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin in Patients with Previously Untreated, High-Risk Acute Promyelocytic Leukemia
Morgantown : West Virginia University - Clinical Trials Research Unit
S0805 - Phase II Study of Combination of Hyper-CVAD and Dasatinib with or without allogeneic stem cell transplant in Patients with Philadelphia(Ph)Chromosome Postive and/or Bcr-Abl Positive Acute Lymphoblastic Leukemia(ALL)
View More »
Martinsburg : City Hospital - West Virginia University Hospital East
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Morgantown : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Morgantown : Investigational Site Number 840002
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Morgantown : West Virginia University Hospital
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
Morgantown : Department of Medicine Section of Hematology/Oncology, West Virginia University Hospitals, Mary Babb Randolph Cancer Center, West Virginia University
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Wheeling : Wheeling Hospital
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Wisconsin
Green Bay : St. Vincent Hospital/Green Bay Oncology
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Green Bay : St Vincent Hospital
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Green Bay : St Vincent Regional Cancer Center
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Green Bay : Bellin Memorial Hospital
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Janesville : Mercy Health System Heme/Onc
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
View More »
LaCrosse : Gundersen Clinic
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Madison :
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma
Madison : University of Wisconsin
An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Madison : Kenneth DeSantes., MD
Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors
Madison : University of Wisconsin Carbone Cancer Center
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Madison : University of Wisconsin
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
Marshfield : Marshfield Clinic
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Milwaukee : Medical College of Wisconsin
A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Milwaukee : Medical College of Wisconsin
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Milwaukee : Medical College of Wisconsin
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Milwaukee : Children's Hospital of Wisconsin Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Milwaukee : The Medical College of Wisconsin
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Milwaukee : GSK Investigational Site
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Milwaukee : Medical College of Wisconsin
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Milwaukee : Medical College Of Wisconsin
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Milwaukee : Medical College of Wisconsin
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Milwaukee : Medical College of Wisconsin
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Oconomowoc : Oconomowoc Memorial Hospital
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Waukesha : Waukesha Memorial Hospital
Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Waukesha : Waukesha Memorial Hospital
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Wausau : Aspirus Regional Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Wisconsin Rapids : Riverview Hospital
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Argentina
Buenos Aires :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Buenos Aires : Updated
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Buenos Aires : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Buenos Aires : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Buenos Aires : Novartis Investigative Site
Randomized ph Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib
View More »
Buenos Aires : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Buenos aires : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Bunos Aires : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Ciudad Autonoma de Buenos Aires : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Cordoba : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Córdoba : Updated
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
El Palomar : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
La Plata : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Rio Negro : Novartis Investigative Site
Randomized ph Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib
Rio Negro : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Australia
Adelaide : IMVS
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Adelaide : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Adelaide : Royal Adelaide Hospital, Site #951
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Adelaide : Royal Adelaide Hospital
Study of KB004 in Subjects With Hematologic Malignancies
Adelaide : Haematology and Bone Marrow Transplant Unit, Royal Adelaide Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
View More »
Bedford Park : Flinders Medical Centre
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Camperdown : Royal Prince Alfred Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Clayton : Investigational Site Number 036002
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Clayton : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Concord : Concord Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Concord : Concord Repatriation General Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Darlinghurst : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
East Melbourne : Peter MacCallum Cancer Centre
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
East Melbourne : Peter MacCallum Cancer Centre
A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia
East Melbourne : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
East Melbourne : The Peter MacCallum Cancer Center, Site #950
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Fitzroy : St. Vincent's Hospital
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Fitzroy : Updated
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Fitzroy : St. Vincent's Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Frankston : Frankston Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Garran : The Canberra Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Geelong : Andrew Love Cancer Center, Geelong Hospital, Barwon Health
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Gosford : Haematology Department, Gosford Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Herston : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Herston : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Herston : Local Institution
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Herston, Brisbane : Royal Brisbane and Women's Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Hobart : Investigational Site Number 036001
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Kingswood : Investigational Site Number 036005
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Kingswood : Nepean Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Kogarah : Updated
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Kogarah : The St. George Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Kurralta Park : Updated
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Malvern : Cabrini Hospital
A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia
Melbourne :
A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia
Melbourne : Box Hill Hospital, Site #940
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Melbourne : The Alfred Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Nedlands : Sir Charles Gairdner Hospital
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Nedlands : Sir Charles Gairdner Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Nedlands : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
New Lambton Heights :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
North Adelaide : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Parkville : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Parkville : Royal Melbourne Hospital
A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission
Parkville :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Parkville : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Parkville : Department of Clinical Haematology and BMT Service, Royal Melbourne Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Perth : Investigational Site Number 036003
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Perth : Local Institution
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Perth : Royal Perth Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Prahran : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Prahran : The Alfred Hospital
Study of KB004 in Subjects With Hematologic Malignancies
Randwick : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Randwick : The Sydney Children's Hospital, Centre for Children's Cancer and Blood Disorders
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Randwick : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
St. Leonards : Royal North Shore Hospital
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
St. Leonards : Royal North Shore Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
St. Leonards : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Sydney : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Westmead :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Westmead : The Children's Hospital at Westmead, Department of Oncology
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Westmead : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Westmead : Westmead Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Westmead, NSW : Children's Hospital at Westmead
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Woolloongabba : Princess Alexandra Hospital
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Woolloongabba : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Austria
Dornbirn : Krankenhaus Dornbirn, Abt. für Kinder- und Jugendheilkunde
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Feldkirch : LKH Feldkirch, Interne E
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Feldkirch : LKH Feldkirch, Interne E
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Graz : Univ. Klinik fur Innere Medizin
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Graz : 1102 - LKH Graz
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
View More »
Graz : Univ.-Kinderklinik Graz, Abt. Pädiatrische Hämato-Onkologie
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Graz : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Graz : Universitatsklinik Graz, Universitatsklinik fur Innere Medizin, Abteilung fur Hamatologie
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Hall : A.ö. Bezirkskrankenhaus Hall in Tirol, Innere Medizin / Hämato - Onkologie
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Innsbruck : Novartis Investigative Site
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Innsbruck : Universitätsklinik für Innere Medizin Innsbruck, Klinische Abteilung für Hämatologie und Onkologie
Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL
Innsbruck : Department f. Kinder- u. Jugendheilkunde, Universitätsklinik f. Pädiatrie II
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Innsbruck : Universitätsklinik für Innere Medizin Innsbruck, Klinische Abteilung für Hämatologie und Onkologie
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Innsbruck : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Innsbruck : Medical University Innsbruck, Division of Hematology and Oncology
NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)
Innsbruck : GSK Investigational Site
Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia
Innsbruck : Medizinische Universität Innsbruck
Protocol in Acute Myeloid Leukemia With FLT3-ITD
Innsbruck : Universitätsklinik Innsbruck, Innere MEdizin IV / Hämato-Onkologie
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Innsbruck : University Hospital for Internal Medicine V, Innsbruck Medical University
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Klagenfurt : A.oe. Landeskrankenhaus Klagenfurt, Abt. für Kinder- und Jugendheilkunde
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Krems : Landesklinikum Krems, Hämato-onkologisches Service
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Kufstein : A.ö. Bezirkskrankenhaus Kufstein, Innere Medizin / Hämatologie / Onkologie
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Leoben : A.oe. Landeskrankenhaus Leoben, Abt. für Kinder und Jugendliche
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Linz : Krankenhaus der Barmherzigen
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Linz : 1107 - Krankenhaus der Elisabethinen
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Linz : Landes-Kinderklinik Linz, Haematologie/Onkologie
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Linz : AKH Linz, Innere Medizin 3, Zentrum für Hämatologie und medizinische Onkologie
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Linz : Krankenhaus d. Barmherzigen Schwestern Linz, Interne I
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Linz : Krankenhaus der Elisabethinen Linz GmbH, 1. Interne
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Linz : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Linz : GSK Investigational Site
Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia
Linz : Krankenhaus der Barmherzigen Schwestern Linz
Protocol in Acute Myeloid Leukemia With FLT3-ITD
Linz : Krankenhaus der Elisabethinen Linz GmbH
Protocol in Acute Myeloid Leukemia With FLT3-ITD
Linz : AKH Linz, Department für Innere Medizin 3
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Salzburg : Univ. Klinik fur Innere Medizin III
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Salzburg : 1106
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Salzburg : Universitätsklinik der PMU Salzburg, Univ-Klinik für Innere Medizin III
Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL
Salzburg : St. Johanns Spital / Landeskrankenhaus, Salzburg, Kinderspital Abt. Kinder u. Jugendheilkunde
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Salzburg : Universitaetsklinik der PMU Salzburg, UK f. Innere Medizin III
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Salzburg : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Salzburg : University Hospital Salzburg, Department of Medicine III, Center of Oncology and Hematology
NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)
Salzburg : GSK Investigational Site
Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia
Salzburg : Universitätsklinik für Innere Medizin III Salzburg
Protocol in Acute Myeloid Leukemia With FLT3-ITD
Salzburg : Universitätsklinik der PMU Salzburg, Univ-Klinik für Innere Medizin
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Salzburg : Landeskrankenhaus Salzburg, Universitaetsklinik fur innere Medizin lll, Universitaetsklinikum der PMU
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Steyr : Landeskrankenhaus Steyr, Department of Internal Medicine II (Hematology and Oncology)
NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)
Steyr : Landeskrankenhaus Steyr, Innere Medizin, Hämatologie, Onkologie
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Vienna : Medical University of Viena
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Vienna : Novartis Investigative Site
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Vienna : St. Anna Kinderspital
Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Vienna : 1101 - AKH Wien
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Vienna : For additional information regarding sites for this trial call (919) 465-4648
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Wels : Abteilung für Innere Medizin IV
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Wels : Klinikum Wels-Grieskirchen GmbH, IV. Interne Abteilung
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Wels : Hospital Wels-Grieskrichen, Department of Internal Medicine IV (Hematology and Oncology)
NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)
Wels : Klinikum Wels-Grieskirchen GmbH, Abteilung für Innere Medizin IV
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Wien : Wilhelminenspital
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Wien : Novartis Investigative Site
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
Wien : St. Anna Kinderspital, Zentrum für Kinder- und Jugendheilkunde
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Wien : Hanusch Krankenhaus, 3. Med. Abtlg. Für Hämatologie und Onkologie
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Wien : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Wien : Hanuschkrankenhaus Wien
Protocol in Acute Myeloid Leukemia With FLT3-ITD
Wien : Hanusch Krankenhaus, 3. Med. Abtlg.
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Wien : AKH Wien, Klinische Abteilung für Hämatologie und Hämostaseologie
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Wien : AKH Wien / MedUniWien Universtatsklinik fur Innere Medizin 1
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Belgium
Antwerp : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Antwerp : Ziekenhuis Netwerk Antwerpen
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Antwerpen : Ziekenhuisnetwerk Antwerpen Updated
A Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 Versus Chlorambucil in Patients 65 Years or Older With Treatment-naive Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (RESONATE™-2)
Antwerpen : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Antwerpen : Ziekenhuisnetwerk Antwerpen - AZ Stuivenberg
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
View More »
Antwerpen : GSK Investigational Site
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Antwerpen : Ziekenhuisnetwerk Antwerpen Updated
An Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Who Participated in Study PCYC-1115-CA (PCI-32765 Versus Chlorambucil)
Antwerpen : 1504
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Antwerpen : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Antwerpen : ZNA Middleheim Lindendreef 1
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Antwerpen : ZNA Stuivenberg, Lange Beeldekensstraat 267
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Arlon : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Brasschaat : GSK Investigational Site
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Brugge : Novartis Investigative Site
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Brugge : GSK Investigational Site
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Brugge : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Brugge : AZ St.-Jan Brugge-Oostende AV
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Brugge : AZ St Jan AV
TK008: Efficacy Study on the Strategy of Herpes Simplex Virus Thymidine Kinase Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia
Brugge : 1230.14.32002 Boehringer Ingelheim Investigational Site
Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)
Brügge : 1505
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Brussels : 1502 - Cliniques Universitaires de Saint-Luc
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Brussels : Institute Jules Bordet, Department of Hematology
NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)
Brussels : Cliniques universitaires Saint-Luc
NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)
Brussels : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Brussels : Cliniques Universitaires Saint Luc
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Bruxelles : Investigational Site Number 056003
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Bruxelles : Hopital Des Enfants Reine Fabiola
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Bruxelles : Hopital Saint Luc
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Bruxelles : 1270.1.32001 Boehringer Ingelheim Investigational Site
BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)
Bruxelles : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Edegem : UZ Antwerpen
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Gent : UZ Gent
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Gent : Investigational Site Number 056002
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Gent : UZ Gent
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Gent : 1270.1.32003 Boehringer Ingelheim Investigational Site
BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)
Gent : 1503
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Gent : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Gent : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Gent : Universitair Ziekenhuis Gent
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Godinne : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Haine-Saint Paul : Hopital de Jolimont
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Haine-saint-Paul : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Haine-Saint-Paul : 1230.14.32007 Boehringer Ingelheim Investigational Site
Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)
Hasselt : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Kortrijk : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Kortrijk : AZ Groeninge
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Leuven : Novartis Investigative Site
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Leuven : UZ Leuven
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Leuven : Investigational Site Number 056001
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Leuven : GSK Investigational Site
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Leuven : 1270.1.32002 Boehringer Ingelheim Investigational Site
BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)
Leuven : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Leuven : University Hospital Gasthuisberg, Department of Hematology
NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)
Leuven : UZ Gasthuisberg - Department of Hematology, Site #700
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Leuven : UZ Leuven, campus Gasthuisberg, Department of Haematology
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Leuven : University Hospitals Leuven
TK008: Efficacy Study on the Strategy of Herpes Simplex Virus Thymidine Kinase Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia
Liege : Chr de La Citadelle
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Liege : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Mons : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Montegnee : Chc Esperance
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Montigny-Le Tilleul : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Roeselare : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Roeselare : H. Hartziekenhuis Roeselare-Menen vzw
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Roeselare : H.-Hartziekenhuis Roeselare - Menen vzw
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Roeselare : 1230.14.32008 Boehringer Ingelheim Investigational Site
Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)
Turnhout : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Wilrijk : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Yvoir : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Yvoir : Novartis Investigative Site
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Yvoir : 1501 - Cliniques Universitaires UCL de Mont Godinne
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Yvoir : CHU de Mont-Godinne
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Yvoir : 1230.14.32004 Boehringer Ingelheim Investigational Site
Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)
Brazil
Barretos : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Barretos : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Curitiba : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Goiania : Updated
CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Goiania : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
View More »
Jaú : Novartis Investigative Site
Randomized ph Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib
Porto Alegre : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Porto Alegre : Updated
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Porto Alegre : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Porto Alegre : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Rio de Janeiro : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Salvador : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Sao Paulo : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Sao Paulo : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Sao Paulo : Updated
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
São Paulo : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
São Paulo : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
São Paulo : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Bulgaria
Sofia : GSK Investigational Site
Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia
Canada
Calgary :
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Calgary : Alberta Children's Hospital
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Calgary : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Calgary : Alberta Children's Hospital
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Edmonton : Novartis Investigative Site
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
View More »
Edmonton : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Edmonton :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Greenfield Park : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Greenfield Park : Charles LeMoyne Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Halifax : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Halifax : Updated
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Halifax : CDHA Centre for Clinical Research
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Halifax : GSK Investigational Site
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Halifax : Queen Elizabeth II Health Sciences Centre
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Hamilton : McMasters University Medical Center Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Hamilton : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Kirkland : Merck Frosst Canada Ltd.
Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM3)
Kitchener : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
London : Local Institution
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Montreal : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Montreal : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Montreal : Novartis Investigative Site
A Phase II, Single Arm, Open Label Study of Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Montreal :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Montreal :
A Study of RO5503781 as Single Agent or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
Montreal : Updated
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Montreal : Royal Victoria Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Montreal : Hopital Maisonneuve Rosemont
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Montreal : GSK Investigational Site
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Montreal : Hopital Ste. Justine
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Montreal : The Montreal Children's Hospital
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Montreal : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Montreal : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Montreal : Local Institution
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Montreal : Jewish General Hospital, Site #129
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Ottawa : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Quebec : Hopital de L'Enfant-Jesus
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Québec : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Saint John : Saint John Regional Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Sainte-Foy : Quebec Children's Hospital Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Sherbrooke : Updated
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Sherbrooke : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
St. Catherine : Hospital St. Justine Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
St. John : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
St. John : Atlantic Health Sciences Corporation, Saint John Regional Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
St. Johns : Health Sciences Center
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Toronto :
A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia
Toronto : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Toronto : Novartis Investigative Site
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Toronto : Univ. Health Network-Princess Margaret Hospital
A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia
Toronto : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Toronto : Novartis Investigative Site
A Phase II, Single Arm, Open Label Study of Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Toronto : Sick Children's Hospital Updated
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Toronto :
A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
Toronto :
A Study of RO5503781 as Single Agent or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
Toronto : Princess Margaret Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Toronto : Updated
An Extension Study of RO5045337 in Patients Participating in Previous Cancer Studies
Toronto : University Health Network-Princess Margaret Hospital
An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)
Toronto : Princess Margaret Hospital
Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy
Toronto : Research Site
CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Toronto : University Health Network, Princess Margaret Hospital
Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients
Toronto : Hospital for Sick Children
Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Toronto : Novartis Investigative Site
Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy
Toronto : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Toronto : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Toronto : University Health Network - Princess Margaret Hospital
Open-Label Study of Lenalidomide in Combination With Oral Dexamethasone in the Treatment of Previously Untreated, Symptomatic Patients With Chronic Lymphocytic Leukemia
Toronto : University Health Network, Princess Margaret Hospital, Site #083
Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Toronto : Princess Margaret Hospital
Safety and Efficacy Study of Nilotinib Combined With Mitoxantrone, Etoposide, and High-dose Cytarabine Induction Chemotherapy Followed by Consolidation for Patients With C-kit Positive Acute Myeloid Leukemia
Toronto : Research Site
Safety and Tolerability of AZD1208 and the Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients
Toronto : Princess Margaret Hospital
SGI-110 in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Toronto : Princess Margaret Hospital
Study Elesclomol Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Toronto : University Health Network, Princess Margaret Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Toronto : Hospital for Sick Kids
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Vancouver : Local Institution
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib
Vancouver : Leukemia BMT program of BC, Vancouver General Hospital, Hematology Research and Clinical Trials Unit
A Study Investigating the Predictive Value of Philadelphia Positive Stem Cell Properties in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase Receiving Treatment With Imatinib
Vancouver :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Vancouver : Children's & Women's Health Centre of British Columbia
MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Vancouver : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Vancouver : Division of Hematology, Vancouver General Hospital
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Winnipeg : CancerCare Manitoba
A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia
Chile
Santiago : Updated
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
China
Beijing :
A Study of RO5072759 (GA101) in Patients With CD20+-Malignant Lymphoma
Beijing : Beijing Clinical Service Center
Bortezomib in Combination With Liposomal Doxorubicin and Dexamethasone to Treat Plasma Cell Leukemia
Guangzhou :
A Study of RO5072759 (GA101) in Patients With CD20+-Malignant Lymphoma
Hong Kong : Department of Paediatrics and Adolescent Medicine, The University of Hong Kong
A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma
Shanghai :
A Study of RO5072759 (GA101) in Patients With CD20+-Malignant Lymphoma
View More »
Shanghai : Shanghai Jiaotong University School of Medicine Ruijin Hospital
Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body
Tianjin : Hematologic hospital of Chinese academy of medical sciences
Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia
Colombia
Monteria : Novartis Investigative Site
Randomized ph Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib
Croatia
Zagreb : Updated
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Czech Republic
Bmo : Pfizer Investigational Site
A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia
Brno :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Brno : Lekarna fakultni nemocnice V Brne
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Brno : University Hospital Brno, Department of Pediatric Oncology
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Brno : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
View More »
Brno : FN Brno
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Brno : University Hospital Brno
Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia
Brno : Fakultni nemocnice Brno, Interni hematoonkologicka klinika
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Brno - Bohunice : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
České Budějovice : Regional Hospital České Budějovice, Department of Pediatrics
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Hradec Kralove : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Hradec Kralove : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Hradec Kralove : FN Hradec Kralove
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Hradec Kralove : Fakultni nemocnice Hradec Kralove, 2. Interni klinika-oddeleni klinicke hematologie
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Hradec Králové : University Hospital Hradec Králové, Department of Pediatrics
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Novy Jicin : Oncology Centre J.G. Mendela
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Olomouc : University Hospital Olomouc, Department of Pediatrics
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Olomouc : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Olomouc : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Olomouc : FN Olomouc
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Ostrava-Poruba : Teaching Hospital Ostrava-Poruba, Department of Pediatrics
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Plzen : Faculty Hospital Plzen
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Plzeň : University Hospital Plzeň, Department of Pediatrics
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Prague : General Faculty Hospital 1 - Internal Clinic
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Praha : VFN Praha 2
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Praha : FN Kralovske Vinohrady
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Praha : Fakultni nemocnice Kralovske Vinohrady, Oddeleni klinicke hematologie
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Praha 10 :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Praha 2 : GSK Investigational Site
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Praha 2 : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Praha 2 : Novartis Investigative Site
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
Praha 5 : University Hospital Motol, Department of Pediatric Hematology and Oncology
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Ústí nad Labem : Masaryk´s Hospital Ústí nad Labem, Department of Pediatrics
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Denmark
Aalborg : GSK Investigational Site
Observational Study of Nelarabine in Children and Young Adults
Copenhagen : Rigshospitalet University Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Copenhagen : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Copenhagen : Copenhagen University Hospital Rigshospital
Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL)
Herlev : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
View More »
Herlev : Herlev Hospital
Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL)
Koebenhavn Oe : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Roskilde : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Vejle : Vejle Hospital
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Egypt
Cairo : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Finland
Helsinki : Pfizer Investigational Site
A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia
Tampere : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
France
Aix En Provence :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Albi :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Amiens : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Amiens : Groupe Hospitalier Sud
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Amiens : Hopital Nord
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
View More »
Amiens : CHU d'Amiens
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Amiens : Service d'hématologie pédiatrique CHRU
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Angers : Chu D'Angers
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Angers :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Angers : CHU d'Angers
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Angers : CHU d'Angers
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Angers : 1211 - CHU d'Angers
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Angers : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Angers : CHU Angers
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Angers : Mathilde HUNAULT BERGER
Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)
Angers : CHU Angers Service de Medecine D - Maladies du Sang
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Angers Cedex 01 : CHU Angers, Service des maladies du sang
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Antibes :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Argenteuil : CH Victor Dupouy
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Argenteuil : Hopital Victor Dupouy
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Argenteuil :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Arras :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Avignon :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Avignon : CHU Avignon Centre Hospitalier Henri Dufaut
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Bayonne : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Bayonne : Ch de La Cote Basque
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Bayonne :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Bayonne : Centre hospitalier de la côte Basque
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Besancon : Hopital Jean Minjoz
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Besancon : Hopital Saint Jacques
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Besancon : Service hématologie pédiatrique Hôpital Saint-Jacques
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Besançon : 1210 - CHU de Besançon
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Besançon : Hôpital Jean Minjoz
TK008: Efficacy Study on the Strategy of Herpes Simplex Virus Thymidine Kinase Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia
Beziers :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Blois :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Blois cedex : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Bobigny : Hopital Avicenne
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Bobigny : Hopital Avicenne
A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q
Bobigny :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Bobigny : Hôpital Avicenne Hématologie Clinique
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Bobigny : Hopital Avicenne- Departement Onco-hematologie
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Bobigny Cedex : Novartis Investigative Site
A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Bobigny Cedex : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Bordeaux : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Bordeaux : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Bordeaux : Service d'Hematologie - Institut Bergonié
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Bordeaux : Hopital Pellegrin Enfants
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Bordeaux :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Bordeaux : Novartis Investigative Site
Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Bordeaux : Novartis Investigative Site
Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy
Bordeaux : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Bordeaux : Service d'hémato-oncologie - Hôpital des Enfants Pellegrin
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Bordeaux cedex : GSK Investigational Site
Observational Study of Nelarabine in Children and Young Adults
Boulogne :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Bourg En Bresse :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Brest :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Brest : Hôpital Morvan
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Caen : Chu Cote de Nacre
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Caen :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Caen : CHU Caen Hématologie Clinique
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Caen : Hématologie oncologie pédiatrique-CHU Caen
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Caen cedex 5 : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Carcassonne :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Castelnau Lez :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Cedex : CHU Côte de Nacre
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Cergy Pontoise : 1206 - Hôpital de Pontoise
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Cergy Pontoise : CH René Dubos
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Chalon Sur Saone :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Chambery :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Clamart : Hôpital Militaire Percy
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Clermont : Service d'Hematolgie Clinique - CHU Estaing
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Clermont Ferrand : Chu Estaing
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Clermont Ferrand :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Clermont Ferrand Cedex 1 :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Clermont-Ferrand : CHU Estaing
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Clermont-Ferrand : CHU Estaing Service d'hématologie
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Clermont-Ferrand : CHU de Clermont-Ferrand
Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia
Clermont-Ferrand : Hémato-Oncologie et Thérapie Cellulaire Pédiatrique - Hôtel Dieu
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Clermont-Ferrand Cedex 1 : GSK Investigational Site
Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia
Colmar :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Corbeil Essonnes :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Corbeil Essonnes : Centre hospitalier sud francilien
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Courbevoie : Laboratoires Merck Sharp & Dohme - Chibret Updated
A Study of Dinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974 AM1)
Creil :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Creteil : Hôpital Henri Mondor
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Creteil : Hôpital Henri Mondor
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Creteil :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Creteil : Hopital Henri Mondor
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Creteil : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Créteil : 1205 - CHU Henri Mondor
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Créteil : Hôpital Henri Mondor
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Dijon :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Dijon : Hopital Du Bocage
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Dijon : Dijon hôpital d'enfants
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Dijon : Hémato-Oncologie Pédiatrique - Hôpital d'Enfants
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Frejus :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Grenoble : Chu Grenoble
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Grenoble :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Grenoble : CHU de Grenoble
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Grenoble : CHU de Grenoble
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Grenoble : Hôpital Michallon
Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia
Grenoble : Pédiatrie CHU - Hôpital Nord
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Grenoble cedex 9 : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
La Tronche :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Le Chesnay : Ch de Versailles - Hopital Mignot
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Le Chesnay : Hopital Mignot
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Le Mans : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Le Mans :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Libourne :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Libourne Cedex : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Lille :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Lille : Chru Lille
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Lille : Chru Lille - Hop Jeanne de Flandres
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Lille : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Lille : CHRU - Hopital Claude HURIEZ
Phase I Study of ONO-4059 Given as Monotherapy in Patients With Relapsed/Refractory NHL and CLL
Lille : CHU Lille Hôpital Claude Huriez
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Lille : Hôpital Jeanne de Flandre
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Lille : CHU Lille, Service des maladies du sang, Hopital Huriez
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Lille cedex : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Lille Cedex : GSK Investigational Site
Observational Study of Nelarabine in Children and Young Adults
Lille cedex : GSK Investigational Site
Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia
Limoges : Chu Dupuytren
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Limoges : CHU Limoges Hopital Dupuytren
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Limoges : Limoges University Hospital
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Lyon : Institut Hematologie Oncologie Pediatrique
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Lyon :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Lyon : 1209 - CHU de Lyon
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Lyon : Centre hospitalier Lyon Sud
Phase I Study of ONO-4059 Given as Monotherapy in Patients With Relapsed/Refractory NHL and CLL
Lyon : Hôpital Edouard Herriot
Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia
Lyon : Hôpital DEBROUSSE Institut d'hématologie et d'oncologie pédiatrique
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Lyon : Xavier THOMAS
Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia
Lyon cedex 04 : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Lyon Cedex 08 : Novartis Investigative Site
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
Macon :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Marseille : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Marseille : Institut Laoli Calmettes
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Marseille :
A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
Marseille : Chu Timone Enfants
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Marseille : Institut Paoli Calmettes
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Marseille :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Marseille : Novartis Investigative Site
Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy
Marseille : Institute Paoli Calmettes
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Marseille : Institut Paoli Calmettes
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Marseille Cedex 09 : 1270.1.33002 Boehringer Ingelheim Investigational Site
BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)
Marseille Cedex 09 : Institut Paoli - Calmettes
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Marseille Cedex 09 : GSK Investigational Site
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Marseille cedex 9 : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Marseille Cedex 9 : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Marseille Cedex 9 : Local Institution
Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Maseille : Service hématologie pédiatrique CHU la Timone
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Meaux : Centre Hospitalier de Meaux
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Meaux : CH de Meaux
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Metz :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Metz Tessy :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Montauban :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Montpellier :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Montpellier :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Montpellier : Investigational Site Number 250002
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Montpellier : Hopital Saint Eloi
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Montpellier :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Montpellier : Guillaume CARTRON
Intensified Rituimab Prephase Before FCR in Untreated B-CLL
Montpellier : CHU St Eloi
Phase I Study of ONO-4059 Given as Monotherapy in Patients With Relapsed/Refractory NHL and CLL
Montpellier : Hôpital Arnaud de Villeneuve
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Montpellier Cedex 5 : 1270.1.33001 Boehringer Ingelheim Investigational Site
BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)
Montpellier Cedex 5 : CHU Saint Eloi
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Mulhouse : Hopital Emile Muller
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Mulhouse :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Mulhouse : Centre Hospitalier de Mulhouse
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Mulhouse : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Nancy : CHU Brabois
A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q
Nantes :
A Study of RO5429083 Alone or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
Nantes : Hopital Mere Enfant
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Nantes : Hotel Dieu
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Nantes :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Nantes : Hôpital de l'hôtel Dieu
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Nantes : 1212 - Hôpital de l'hôtel Dieu
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Nantes : CHU de Nantes
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Nantes : CHR Hôtel Dieu
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Nantes : CHU Nantes Hotel Dieu, Service d'hematologie clinique
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Nantes Cedex : CHU Hotel Dieu
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Nantes Cedex 01 : Investigational Site Number 250006
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
Nantes cedex 1 : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Nice : Hopital de l'Archet 1
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Nice : Hopital de L'Archet 2
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Nice :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Nice : 1213 - Centre Hospitalier Universitaire de Nice
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Nice : Centre Antoine Lacassagne
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Nice : Hôpital de L'archet I
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Nice : Hôpital de l'Archet
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Nimes :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Nimes Cedex : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Orleans :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Paris : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Paris : Hopital Saint Louis
A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q
Paris : Novartis Investigative Site
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
Paris : Updated
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Paris : Hopital Hotel Dieu
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Paris : Hopital Armand Trousseau
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Paris : Hopital Robert Debre
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Paris : Hopital Saint Louis
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Paris : Hopital Necker Enfants Malades
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Paris : Hopital Saint Antoine
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Paris :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Paris : Hôpital Saint Antoine
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Paris : Hôpital Saint Louis
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Paris : 1201 - Hôpital Saint Louis
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Paris : Hôpital Saint-Louis
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Paris : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Paris : Novartis Investigative Site
Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr).
Paris : Hôtel Dieu Sce Hématologie Clinique
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Paris : Hôpital Saint-Antoine
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Paris : Service hématologie Hopital Necker
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Paris : Hématologie Pédiatrique - Hôpital Trousseau
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Paris : Hémato-immunologie-Robert Debré
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
Paris : Children Armand Trousseau Hospital
Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2
Paris Cedex 10 : Local Institution
Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Paris cedex 12 : GSK Investigational Site
Observational Study of Nelarabine in Children and Young Adults
Paris Cedex 13 :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Paris Cedex 15 : Hôpital Necker
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Paris Cedex 19 : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Paris Cedex 19 : Hopital Robert Debré (AP-HP)
Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Perpignan : Ch de Perpignan
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Perpignan :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Perpignan : CH Saint-Jean
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Perpignan : CHU Perpignan Centre Hospitalier Hôpital Saint-Jean
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Pessac : Research Site Updated
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Pessac :
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Pessac : Hopital Haut-Leveque
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Pessac : Hôpital Haut Lévêque
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Pessac : 1202 - CHU de Bordeaux - Hôpital Haut Lévêque
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL
Pessac : CHU de Bordeaux - Hôpital Haut-Lévêque
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Pessac : CHU de Bordeaux- Hopital Haut-Leveque, Centre Francois Magendle
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Pessac cedex : GSK Investigational Site
Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy
Pessac cedex : GSK Investigational Site
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Pierre Benite :
A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DCDS4501A in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Pierre Benite : Hopital Lyon Sud
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia
Pierre Benite :
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia
Pierre Benite : Updated
CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Pierre Benite : Centre Hospitalier Lyon Sud - Service d'Hematologie - Pavillon Marcel Berard - Bat. 1G - 1er etage, 165 Chemin du grand Revoyet
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Pierre Benite : Local Institution
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Pierre Bénite : Centre hospitalier Lyon Sud
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Pierre Benite Cedex : Investigational Site Number 250001
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
